About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
954 genotypes with 1308 annotations displayed of selected term and subterms
Searched Term: seizures
Allelic Composition
(Genetic Background)		 Annotated Term Reference
Achetm4Pata/Achetm4Pata
(involves: 129X1/SvJ * Black Swiss * C57BL/6 * FVB) 		seizures J:147855
Acp2tm1Psa/Acp2tm1Psa
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J) 		tonic-clonic seizures J:41986
Adam22tm1Sag/Adam22tm1Sag
(either: B6.Cg-Adam22tm1Sag or (involves: C57BL/6 * C57BL/6N * CBA)) 		convulsive seizures J:99692
Adamts4tm1Dgen/Adamts4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Adarb1tm1Phs/Adarb1tm1Phs
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:63273
Adgrv1frings/Adgrv1frings
(RB/1) 		audiogenic seizures J:25341
Adgrv1frings/Adgrv1frings
(BUB/BnJ) 		audiogenic seizures J:97534
Adgrv1tm1Msat/Adgrv1tm1Msat
(involves: 129P2/OlaHsd * C57BL/6J) 		audiogenic seizures J:95518
Adgrv1tm1Msat/Adgrv1tm1Msat
(B6.129P2-Adgrv1tm1Msat) 		audiogenic seizures J:95518
Adgrv1tm1Pwh/Adgrv1tm1Pwh
(involves: 129S1/Sv * C57BL/6J) 		audiogenic seizures J:90899
Adktm2Bois/Adktm2Bois
Adora1tm1Bbf/Adora1tm1Bbf
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		environmentally induced seizures J:237189
Adktm2Bois/Adktm2Bois
Adora2atm1Jfc/Adora2atm1Jfc
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased susceptibility to induction of seizure by inducing agent J:237189
Adktm2Bois/Adktm2Bois
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		convulsive seizures J:237189
environmentally induced seizures J:237189
increased susceptibility to pharmacologically induced seizures J:237189
Adora2btm1.1(KOMP)Vlcg/Adora2b+
(B6N(Cg)-Adora2btm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
Adra2atm1Bkk/Adra2atm1Bkk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal spike wave discharge J:197965
Agpat1tm1Garg/Agpat1tm1Garg
(involves: 129S6/SvEvTac * C57BL/6) 		audiogenic seizures J:250301
Aifm1Hq/Y
(B6CBACa Aw-J/A-Aifm1Hq/J) 		abnormal seizure response to pharmacological agent J:98103
Aifm1Hq/Aifm1Hq
(B6CBACa Aw-J/A-Aifm1Hq/J) 		abnormal seizure response to pharmacological agent J:98103
Akap5tm1.1Jsco/Akap5tm1.1Jsco
(involves: 129S * C57BL/6 * FVB/N) 		decreased susceptibility to pharmacologically induced seizures J:138972
Akt3Nmf350/Akt3+
(C57BL/6J-Akt3Nmf350) 		abnormal seizure response to electrical stimulation J:169028
increased susceptibility to pharmacologically induced seizures J:169028
maximal tonic hindlimb extension seizures J:169028
sporadic seizures J:169028
tonic-clonic seizures J:169028
Akt3Nmf350/Akt3Nmf350
(C57BL/6J-Akt3Nmf350) 		abnormal seizure response to electrical stimulation J:169028
increased susceptibility to pharmacologically induced seizures J:169028
maximal tonic hindlimb extension seizures J:169028
tonic-clonic seizures J:169028
Akt3tm1Mbb/Akt3tm1Mbb
(involves: C57BL/6J) 		abnormal seizure response to electrical stimulation J:169028
maximal tonic hindlimb extension seizures J:169028
tonic-clonic seizures J:169028
Aldh5a1tm1Kmg/Aldh5a1tm1Kmg
(involves: 129/Sv * C57BL/6) 		absence seizures J:91856
myoclonus J:71949
tonic seizures J:71949
Aldh7a1tm1d(EUCOMM)Hmgu/Aldh7a1tm1d(EUCOMM)Hmgu
(B6(FVB)-Aldh7a1tm1d(EUCOMM)Hmgu) 		seizures J:298561
Aldh7a1tm1d(EUCOMM)Hmgu/Aldh7a1tm1d(EUCOMM)Hmgu
(129S1.B6N(FVB)-Aldh7a1tm1d(EUCOMM)Hmgu) 		seizures J:298561
Alg13em1Bayu/Y
(involves: C57BL/6J) 		environmentally induced seizures J:275180
increased susceptibility to pharmacologically induced seizures J:275180
Alpltm1Jlm/Alpltm1Jlm
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J)) 		seizures J:39015
Alpltm1Sor/Alpltm1Sor
(either: (involves: 129S7/SvEvBrd-Alpltm1Sor) or (involves: 129S7/SvEvBrd * C57BL/6)) 		seizures J:28394
Amphtm1Pdc/Amphtm1Pdc
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:75306
tonic seizures J:75306
Ank3tm1Bnt/Ank3tm1Bnt
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:51377
Ano3tm1.1Lyj/Ano3tm1.1Lyj
Ptgdstm1.1(cre)Gvn/Ptgds+
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		environmentally induced seizures J:310618
Ano3tm1.1Lyj/Ano3tm1.1Lyj
Tg(Nes-cre)1Kln/0
(involves: 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:310618
Ap3b2m1J/Ap3b2m1J
(C57BL/6J-Ap3b2m1J/FrkJ) 		tonic-clonic seizures J:205908
Ap3b2m2J/Ap3b2m2J
(B6;129S-Ap3b2m2J/GrsrJ) 		tonic-clonic seizures J:222308, J:205908
Ap3b2tm1Bur/Ap3b2tm1Bur
(C57BL/6-Ap3b2tm1Bur) 		tonic-clonic seizures J:94942
Ap3d1mh-2J/Ap3d1mh-2J
(involves: C3H/HeJ * C57BL/6J * CAST/Ei) 		abnormal spike wave discharge J:59842
Ap3d1mh/Ap3d1mh
(STOCK Mfsd12gr +/+ Ap3d1mh/J) 		abnormal spike wave discharge J:59842
Ap3m2tm1Ohno/Ap3m2tm1Ohno
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal kindling response J:93312
increased susceptibility to pharmacologically induced seizures J:93312
nonconvulsive seizures J:93312
seizures J:93312
Apc2tm1Mno/Apc2tm1Mno
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:184856
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc) 		abnormal kindling response J:118390
Arf4tm1.1Tsdk/Arf4+
Arf5tm1.1Tsdk/Arf5tm1.1Tsdk
(B6J.B6N-Arf4tm1.1Tsdk Arf5tm1.1Tsdk) 		abnormal spike wave discharge J:279779
Arhgap32tm1Taki/Arhgap32tm1Taki
(B6N.Cg-Arhgap32tm1Taki) 		increased susceptibility to pharmacologically induced seizures J:236753
Arv1tm1.2Geno/Arv1tm1.2Geno
(involves: C57BL/6 * C57BL/6J) 		seizures J:263695
Arxtm1.1Jno/Y
(involves: 129S7/SvEvBrd * C57BL/6J) 		clonic seizures J:151082
myoclonus J:151082
seizures J:151082
tonic-clonic seizures J:151082
Arxtm1.1Jno/Arxtm1.1Jno
(involves: 129S7/SvEvBrd * C57BL/6J) 		myoclonus J:151082
Arxtm1Gldn/Y
Tg(mI56i-cre,EGFP)1Kc/0
(involves: 129/Sv * C57BL/6 * CD-1 * FVB/N) 		clonic seizures J:148311
sporadic seizures J:148311
tonic-clonic seizures J:148311
Arxtm1Gldn/Arx+
Tg(mI56i-cre,EGFP)1Kc/0
(involves: 129/Sv * C57BL/6 * CD-1 * FVB/N) 		clonic seizures J:148311
convulsive seizures J:148311
sporadic seizures J:148311
tonic-clonic seizures J:148311
Arxtm3Kki/Y
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:152416
Arxtm4Kki/Y
(involves: 129S/SvEv * C57BL/6J) 		abnormal spike wave discharge J:152416
seizures J:152416
tonic seizures J:152416
Arxtm4Kki/Y
(involves: 129S/SvEv * C57BL/6NHsd) 		myoclonus J:260340
Arxtm5Kki/Y
(involves: 129S/SvEv * C57BL/6NHsd) 		myoclonus J:260340
seizures J:260340
Asnsd1Gt(OST460318)Lex/Asnsd1Gt(OST460318)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		environmentally induced seizures J:320329
Asp1/Asp1
(DBA/2J) 		audiogenic seizures J:6355
Asp2/Asp2
(DBA/2J) 		audiogenic seizures J:11261, J:5094
Asp3DBA/2J/Asp3DBA/2J
(DBA/2J) 		audiogenic seizures J:11261
Aspanur7/Aspanur7
(involves: C57BL/6J) 		seizures J:143201, J:226682
Atad1tm1.1Vdaw/Atad1tm1.1Vdaw
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		seizures J:173768
Atad1tm1Vdaw/Atad1tm1Vdaw
Tg(Camk2a-cre)2Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		seizures J:173768
Atcayji/Atcayji
(Not Specified) 		seizures J:14903
Ate1tm1Avar/Ate1tm2.1Avar
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		seizures J:155421
tonic-clonic seizures J:155421
Atox1Gt(IRESBetageo)3Pgr/Atox1Gt(IRESBetageo)3Pgr
(B6.129(Cg)-Atox1Gt(IRESBetageo)3Pgr/Mmucd) 		seizures J:74249
Atp1a3Myk/Atp1a3+
(B6NCr.129S1-Atp1a3Myk) 		abnormal seizure response to inducing agent J:180250
abnormal spike wave discharge J:151948
convulsive seizures J:151948
environmentally induced seizures J:151948
Atp1a3Myk/Atp1a3+
(involves: 129S1/SvImJ * C57BL/6J * C57BL/6NCr) 		abnormal spike wave discharge J:151948
convulsive seizures J:151948
environmentally induced seizures J:151948
Atp1a3tm1.1Tmklh/Atp1a3+
(B6JRj.129S1-Atp1a3tm1.1Tmklh) 		increased susceptibility to pharmacologically induced seizures J:254463
Atp1a3tm1Mika/Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal seizure response to inducing agent J:264408
increased kindling response J:264408
seizures J:264408
Atp1a3tm1Ute/Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased kindling response J:262419
increased susceptibility to pharmacologically induced seizures J:262419
seizures J:262419
Atp6v1b2em1Pcamp/Atp6v1b2+
(C57BL/6N-Atp6v1b2em1Pcamp) 		increased susceptibility to pharmacologically induced seizures J:342781
Atp6v1b2em1Pcamp/Atp6v1b2em1Pcamp
(C57BL/6N-Atp6v1b2em1Pcamp) 		environmentally induced seizures J:342781
increased susceptibility to pharmacologically induced seizures J:342781
Atp6v1b2tm1Yoyu/Atp6v1b2tm1Yoyu
(involves: C57BL/6) 		environmentally induced seizures J:278514
Atp7aMo-ml/Y
(C3Hf/He) 		tonic seizures J:40664
Atrnmg-3J/Atrnmg-3J
(C3HeB/FeJ-Atrnmg-3J/J) 		seizures J:96070
Atxn7tm1Hzo/Atxn7+
(involves: 129S7/SvEvBrd * C57BL/6) 		myoclonus J:82072
Avpr1btm1Dgen/Avpr1btm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
B4galnt1tm1Rlp/B4galnt1tm1Rlp
St8sia1tm1Rlp/St8sia1tm1Rlp
(involves: 129S6/SvEvTac) 		audiogenic seizures J:67955
seizures J:67955
tonic-clonic seizures J:67955
Baiap3tm1Smwk/Baiap3tm1Smwk
(B6N.129P2-Baiap3tm1Smwk) 		increased susceptibility to pharmacologically induced seizures J:221234
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm1Sjk
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6) 		seizures J:66872
BckdkGt(VICT48)710Lex/BckdkGt(VICT48)710Lex
(B6.129S5/SvEvBrd-BckdkGt(VICT48)710Lex) 		seizures J:117564
tonic-clonic seizures J:117564
Bdnftm3Jae/Bdnftm3Jae
Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR) 		abnormal kindling response J:91467
Bhlhe40tm1.1Rhli/Bhlhe40tm1.1Rhli
(involves: 129S1/Sv * C57BL/6 * CD-1 * SJL) 		increased susceptibility to pharmacologically induced seizures J:131834
Bidtm1Sjk/Bidtm1Sjk
Cstbtm1Rm/Cstbtm1Rm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		myoclonus J:115694
seizures J:115694
Bis1C57BL/6J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
Bis4A/J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
Bloc1s6pa/Bloc1s6pa
(B6.Cg-Bloc1s6pa/J) 		tonic seizures J:5215
Bmi1tm1Brn/Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB)) 		sporadic seizures J:17712
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1) 		convulsive seizures J:170095
Bsntm1Gund/Bsntm1Gund
(Not Specified) 		clonic seizures J:82241
convulsive seizures J:82241
increased susceptibility to pharmacologically induced seizures J:82241
myoclonus J:82241
C1qatm1Mjw/C1qatm1Mjw
(involves: 129S/SvEv) 		absence seizures J:159281
seizures J:159281
Cacna1arkr/Cacna1arkr
(B6.Cg-Cacna1arkr) 		absence seizures J:71860
Cacna1atg-4J/Cacna1atg-4J
(B6.C3Bir-Cacna1atg-4J) 		absence seizures J:137816
Cacna1atg/Cacna1atg
(B6.D2-Cacna1atg/J) 		increased susceptibility to pharmacologically induced seizures J:6154
seizures J:6154
Cacna1atg/Cacna1atg
(involves: 101 * C3H * C57BL/10 * DBA/2J) 		seizures J:262
sporadic seizures J:262
Cacna1atm1.1Sher/Cacna1atm1.1Sher
Tg(Pcp2-cre)2Mpin/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		abnormal seizure response to inducing agent J:170451
abnormal spike wave discharge J:170451
absence seizures J:170451
environmentally induced seizures J:170451
Cacna1atm1.2Sher/Cacna1atm1.2Sher
(involves: 129S4/SvJae) 		seizures J:170451
Cacna1atm1Hssh/Cacna1atm1Hssh
(involves: C57BL/6J) 		abnormal spike wave discharge J:59076
Cacna1atm1Lory/Cacna1a+
(involves: C57BL/6 * C57BL/6J) 		absence seizures J:258570
Cacna1atm1Nobs/Cacna1atm2Nobs
(involves: 129 * C57BL/6J) 		absence seizures J:155607
Cacna1atm2Nobs/Cacna1atm2Nobs
(involves: 129 * C57BL/6J) 		abnormal spike wave discharge J:155607
absence seizures J:155607
clonic seizures J:155607
Cacna1atm3Maag/Cacna1atm3Maag
(B6.129P2-Cacna1atm3Maag) 		seizures J:144701
Cacna1gtm1Hssh/Cacna1gtm1Hssh
(involves: 129S4/SvJae * C57BL/6J) 		abnormal spike wave discharge J:70557
decreased susceptibility to pharmacologically induced seizures J:70557
Cacna2d2du-2J/Cacna2d2du-2J
(involves: C57BLKS/J-Cacna2d2du-2J/LetJ) 		abnormal spike wave discharge J:70845
absence seizures J:70845
Cacna2d2du-2J/Cacna2d2du-2J
(involves: C57BL/6 * C57BLKS/J) 		absence seizures J:213548
Cacna2d2du-3J/Cacna2d2du-3J
(involves: BALB/cByJ * C57BL/6J) 		myoclonus J:82238
Cacna2d2du/Cacna2d2du
(TKDU/DnJ) 		seizures J:5263
Cacna2d2du/Cacna2d2du
(TKDU) 		seizures J:152373
Cacna2d2ent/Cacna2d2ent
(either: B6.D2-Cacna2d2ent or (involves: C57BL/6J * CD-1 * DBA/2J)) 		seizures J:88967
Cacna2d2tm1Svi/Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:92396
myoclonus J:92396
seizures J:92396
tonic seizures J:92396
Cacnb4lh-2J/Cacnb4lh-2J
(involves: C3H * C57BL/6 * DBA/2J) 		seizures J:137891
Cacnb4lh/Cacnb4lh
(involves: BALB/cGn * C3H/HeSnJ * C57BL/6JEi) 		clonic seizures J:79139
seizures J:1484
tonic seizures J:79139
Cacnb4lh/Cacnb4lh
(involves: BALB/cGn) 		convulsive seizures J:28466
Cacng2stg-3J/Cacng2+
Cacng4tm1Frk/Cacng4+
(involves: B6C3-Cacng2stg-3J/J * B6.129-Cacng4tm1Frk/J) 		absence seizures J:96506
Cacng2stg-3J/Cacng2stg-3J
Cacng4tm1Frk/Cacng4+
(involves: B6C3-Cacng2stg-3J/J * B6.129-Cacng4tm1Frk/J) 		absence seizures J:96506
Cacng2stg-3J/Cacng2stg-3J
Cacng4tm1Frk/Cacng4tm1Frk
(involves: B6C3-Cacng2stg-3J/J * B6.129-Cacng4tm1Frk/J) 		absence seizures J:96506
Cacng2stg-wag/Cacng2stg-wag
(B6.MRL-Cacng2stg-wag/J) 		absence seizures J:96506
Cacng2stg-wag/Cacng2stg-wag
Cacng4tm1Frk/Cacng4tm1Frk
(involves: B6.MRL-Cacng2stg-wag/J * B6.129-Cacng4tm1Frk/J) 		absence seizures J:96506
Cacng2stg/Cacng2stg
(B6C3Fe a/a-Cacng2stg) 		absence seizures J:15527
Camk2atm1.1Oyam/Camk2a+
(either: B6.Cg-Camk2atm1.1Oyam or (involves: C57BL/6 * CBA * ICR)) 		sporadic seizures J:150046
Camk2atm1.1Oyam/Camk2atm1.1Oyam
(either: B6.Cg-Camk2atm1.1Oyam or (involves: C57BL/6 * CBA * ICR)) 		sporadic seizures J:150046
Camk2atm4Sva/Camk2atm4Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac) 		seizures J:79714
Camk2atm5Sva/Camk2atm5Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac) 		seizures J:79714
Camsap1tm1Wem/Camsap1tm1Wem
(involves: C57BL/6J) 		seizures J:296029
Car7tm1.1Kkai/Car7tm1.1Kkai
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:200079
Ccm2tm2.1Sbn/Ccm2tm2.1Sbn
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		seizures J:174085
Cd3em1Btlr/Cd3em1Btlr
(C57BL/6J-Cd3em1Btlr) 		seizures J:132486
Cdk5r1tm1Lht/Cdk5r1tm1Lht
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:38857
seizures J:38857
Cdk5r1tm1Lht/Cdk5r1tm1Lht
(involves: 129S4/SvJae) 		seizures J:38857
Cdkl5tm1.2Cogr/Y
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J) 		abnormal seizure response to inducing agent J:209635
seizures J:209635
Cdkl5tm1.2Cogr/Cdkl5tm1.2Cogr
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J) 		abnormal seizure response to inducing agent J:209635
seizures J:209635
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Cdkn2dtm1Maro/Cdkn2dtm1Maro
(involves: 129X1/SvJ * C57BL/6) 		seizures J:58522
Cdkn2atm1Nesh/Cdkn2atm1Nesh
(involves: 129S6/SvEvTac * FVB/N) 		seizures J:88365
Cdyltm1.1Yuw/Cdyltm1.1Yuw
Emx1tm1(cre)Yql/Emx1+
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:251551
Celf4Ff/Celf4+
(involves: C57BL/6J) 		abnormal seizure response to electrical stimulation J:123744
seizures J:123744
Celf4Ff/Celf4Ff
(involves: C57BL/6J) 		tonic-clonic seizures J:123744
Celf4Ff/Celf4Ff
(involves: C57BL/6J * FVB/NJ) 		absence seizures J:123744
Celf4tm1.1Frk/Celf4tm1.1Frk
Emx1tm1(cre)Krj/?
(involves: 129 * C57BL/6J) 		increased susceptibility to induction of seizure by inducing agent J:19671
Celf4tm1.1Frk/Celf4tm1.1Frk
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6J) 		abnormal spike wave discharge J:181678
convulsive seizures J:181678
Celf4tm1.1Frk/Celf4tm1.1Frk
Tg(Camk2a-cre)1Lfr/0
(involves: 129 * C57BL/6J) 		increased susceptibility to induction of seizure by inducing agent J:194671
Celf4tm1.1Frk/Celf4tm1.1Frk
Tg(Slc32a1-cre)2.1Hzo/0
(involves: 129 * C57BL/6J * FVB) 		decreased susceptibility to induction of seizure by inducing agent J:194671
Celf4tm1.2Frk/Celf4+
(129S1.129(Cg)-Celf4tm1.2Frk/Frk) 		tonic-clonic seizures J:181678
Celf4tm1.2Frk/Celf4tm1.2Frk
(129S1.129(Cg)-Celf4tm1.2Frk/Frk) 		abnormal spike wave discharge J:181678
absence seizures J:181678
seizures J:181678
tonic-clonic seizures J:181678
Celf4tm1.2Frk/Celf4tm1.2Frk
((B6.129(Cg)-Celf4tm1.2Frk/Frk x 129S1.129(Cg)-Celf4tm1.2Frk/Frk)F1) 		abnormal spike wave discharge J:181678
absence seizures J:181678
Celf4tm1.2Frk/Celf4tm1.2Frk
(B6.129(Cg)-Celf4tm1.2Frk/Frk) 		seizures J:181678
tonic-clonic seizures J:181678
Cers1to/Cers1to
(either: FVB/N or (involves: C3H * C57BL/6J * FVB/N)) 		seizures J:91243
Cfl1tm1.1Wit/Cfl1tm1.1Wit
(involves: 129 * C57BL/6 * SJL) 		seizures J:125317
cg/cg
(involves: C57BL/6Ga) 		tonic-clonic seizures J:11941
Chn1tm1.1Abet/Chn1tm1.1Abet
(involves: 129P2/OlaHsd * FVB/N) 		tonic seizures J:128724
Chn1tm2Abet/Chn1tm2Abet
(involves: 129P2/OlaHsd * FVB/N) 		tonic seizures J:128724
Chrna4tm1Dra/Chrna4tm1Dra
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:97020
Chrna4tm1Jbou/Chrna4+
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J)) 		clonic seizures J:118273
seizures J:118273
Chrna4tm1Jbou/Chrna4tm1Jbou
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J)) 		clonic seizures J:118273
seizures J:118273
Chrna4tm2Jbou/Chrna4+
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J)) 		clonic seizures J:118273
seizures J:118273
Chrna4tm2Jbou/Chrna4tm2Jbou
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J)) 		clonic seizures J:118273
seizures J:118273
Chrna5tm1Mdb/Chrna5tm1Mdb
(B6.129-Chrna5tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
Chrna5tm1Mdb/Chrna5tm1Mdb
Chrnb4tm1Mdb/Chrnb4tm1Mdb
(B6.129-Chrnb4tm1Mdb Chrna5tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
Chrna7tm1Bay/Chrna7tm1Bay
(B6.Cg-Chrna7tm1Bay) 		abnormal seizure response to pharmacological agent J:74703
Chrnb2tm1.1Cont/Chrnb2+
(B6.129-Chrnb2tm1.1Cont) 		increased susceptibility to induction of seizure by inducing agent J:228269
Chrnb2tm1.1Cont/Chrnb2tm1.1Cont
(B6.129-Chrnb2tm1.1Cont) 		increased susceptibility to induction of seizure by inducing agent J:228269
Chrnb4tm1Mdb/Chrnb4tm1Mdb
(B6.129-Chrnb4tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
Cittm1Fdc/Cittm1Fdc
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		increased susceptibility to pharmacologically induced seizures J:77297
myoclonus J:77297
Ckbtm1Bew/Ckbtm1Bew
(involves: 129P/Ola * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:89399
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:80901
seizures J:80901
tonic-clonic seizures J:80901
Clcn7tm1.1Lex/Clcn7tm1.1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		tonic seizures J:186049
Cln3tm1Blda/Cln3tm1Blda
(B6.129-Cln3tm1Blda) 		increased susceptibility to pharmacologically induced seizures J:125194
Cln6nclf/Cln6nclf
(involves: C57BL/6J * C57BL/10J * C3HeB/FeJLe) 		seizures J:47292
Cln8mnd/Cln8mnd
(involves: B6.KB2) 		seizures J:47292
Cnptm1(cre)Kan/Cnptm1(cre)Kan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:91814
Cnr1tm1.1Ltz/Cnr1+
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
Cnr1tm1.1Ltz/Cnr1tm1.1Ltz
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
(involves: 129P2/OlaHsd * C57BL/6NCrl) 		increased susceptibility to pharmacologically induced seizures J:122066
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Neurod6tm1(cre)Kan/Neurod6+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6NCrl) 		increased susceptibility to pharmacologically induced seizures J:122066
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Tg(Camk2a-cre)2Gsc/?
(involves: 129P2/OlaHsd * C57BL/6NCrl * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:122066
Cnr1tm2Ltz/Cnr1tm2Ltz
(B6.Cg-Cnr1tm2Ltz) 		increased susceptibility to pharmacologically induced seizures J:199647
Cntn2tm1Fuka/Cntn2tm1Fuka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:67556
sporadic seizures J:67556
Cntn5tm1Kwat/Cntn5tm1Kwat
(involves: 129X1/SvJ * C57BL/6J) 		audiogenic seizures J:89425
Cntnap2tm1Pele/Cntnap2tm1Pele
(B6.129-Cntnap2tm1Pele) 		environmentally induced seizures J:177110
seizures J:177110
Cntnap4tm1Pele/Cntnap4tm1Pele
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		seizures J:211338
Col1a1tm3(CAG-IDH2*R140Q)Kkw/Col1a1+
Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N) 		seizures J:209629
Col2a1sedc/Col2a1sedc
(involves: C57BL/6J) 		seizures J:85735
Col4a1deltaex40/Col4a1+
(B6.129S-Col4a1deltaex40) 		seizures J:215446
Coq8atm1.1Ics/Coq8atm1.1Ics
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N) 		environmentally induced seizures J:249129
increased susceptibility to pharmacologically induced seizures J:249129
Cosz1DBA/2J/Cosz1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cosz2DBA/2J/Cosz2DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cosz3C57BL/6J/Cosz3C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cosz3C57BL/6J/Cosz3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cplx1tm2Bros/Cplx1tm2Bros
(Not Specified) 		sporadic seizures J:86365
CrebbpGt(U-San)112Imeg/Crebbp+
(involves: C57BL/6 * CBA) 		seizures J:53370
Cremtm1.1Endo/Cremtm1.1Endo
(C57BL/6-Cremtm1.1Endo) 		abnormal kindling response J:137666
cri/cri
(involves: DBA/2J) 		clonic seizures J:6110
Cstbtm1Rm/Cstbtm1Rm
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		myoclonus J:50587
Cstbtm1Rm/Cstbtm1Rm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		myoclonus J:115694
seizures J:115694
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Emx1tm1(cre)Yql/Emx1+
(B6.129-Emx1tm1(cre)Yql Ctnnb1tm2Kem) 		increased susceptibility to pharmacologically induced seizures J:92923
seizures J:92923
Ctsdtm1Cptr/Ctsdtm1Cptr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd)) 		seizures J:64892, J:71688
tonic seizures J:64892
Cul4btm1Swl/Y
Edil3Tg(Sox2-cre)1Amc/Edil3+
(B6.Cg-Edil3Tg(Sox2-cre)1Amc Cul4btm1Swl) 		increased susceptibility to pharmacologically induced seizures J:187403
Cyb5d1tm1.1(KOMP)Vlcg/Cyb5d1tm1.1(KOMP)Vlcg
(B6N(Cg)-Cyb5d1tm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
Dbnltm1Jwnd/Dbnl+
(involves: BALB/c) 		convulsive seizures J:109363
Dbptm1Schb/Dbptm1Schb
Hlftm1Schb/Hlftm1Schb
Teftm1Schb/Tef+
(involves: 129P2/OlaHsd * 129S2/SvPas) 		absence seizures J:90854
seizures J:90854
Dbptm1Schb/Dbptm1Schb
Hlftm1Schb/Hlftm1Schb
Teftm1Schb/Teftm1Schb
(involves: 129P2/OlaHsd * 129S2/SvPas) 		absence seizures J:90854
audiogenic seizures J:90854
seizures J:90854
tonic-clonic seizures J:90854
Dclk2tm1.2Jgg/Dclk2tm1.2Jgg
Dcxtm1Caw/Y
(involves: 129/Sv * C57BL/6) 		convulsive seizures J:148345
tonic-clonic seizures J:148345
Dclk2tm1.2Jgg/Dclk2tm1.2Jgg
Dcxtm1Caw/Dcxtm1Caw
(involves: 129/Sv * C57BL/6) 		convulsive seizures J:148345
tonic-clonic seizures J:148345
Del(5D5Mit73-D5Mit351)5Jcs/+
(involves: 129S4/SvJae * C57BL/6J) 		maximal tonic hindlimb extension seizures J:67077
seizures J:67077
Del(5D5Mit388-D5Mit351)4Jcs/+
(involves: 129S4/SvJae * C57BL/6J) 		abnormal seizure response to electrical stimulation J:67077
Del(5Letm1-D5Mit81)3Jcs/+
(involves: 129S4/SvJae * C57BL/6J) 		abnormal seizure response to electrical stimulation J:67077
Del(5Letm1-Htt)1Jcs/+
(involves: 129S4/SvJae * C57BL/6J) 		convulsive seizures J:67077
Del(7Chrna7-Fan1)3Arte/+
(involves: C57BL/6J * C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:260165
abnormal seizure response to pharmacological agent J:260165
decreased susceptibility to pharmacologically induced seizures J:260165
Del(7Gabrb3-Ube3a)1Yhj/+
(B6.129S7-Del(7Gabrb3-Ube3a)1Yhj) 		tonic-clonic seizures J:164010
Del(11Cops3-Rnf112)1Jrl/+
(involves: 129S7/SvEvBrd * C57BL/6) 		seizures J:88027
tonic-clonic seizures J:83302
Del(XArmcx5-Nxf3)3Jw/+
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		environmentally induced seizures J:210663
Del(XNxf2-Nxf3)1Jw/+
(involves: 129S4/SvJae * C57BL/6 * FVB) 		audiogenic seizures J:210663
environmentally induced seizures J:210663
sporadic seizures J:210663
Depdc5tm1c(EUCOMM)Hmgu/Depdc5tm1c(EUCOMM)Hmgu
Tg(Syn1-cre)671Jxm/0
(involves: C57BL/6N * CBA) 		increased susceptibility to pharmacologically induced seizures J:260943
seizures J:260943
tonic seizures J:260943
tonic-clonic seizures J:260943
DgkdGt(RRT600)Byg/DgkdGt(RRT600)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:126380
Dgketm1Ngb/Dgketm1Ngb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		tonic seizures J:68824
Dido1tm3Cmar/Dido1tm3.1Cmar
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6) 		seizures J:328215
Dmtf1tm1Cjs/Dmtf1tm1Cjs
(involves: 129/Sv * C57BL/6) 		seizures J:63444
Dnm1Ftfl/Dnm1+
(C57BL/6J-Dnm1Ftfl) 		abnormal kindling response J:163311
abnormal seizure response to electrical stimulation J:163311
tonic seizures J:163311
Dnm1Ftfl/Dnm1+
(FVB.B6-Dnm1Ftfl/Frk) 		seizures J:235711
Dnm1Ftfl/Dnm1Ftfl
(C57BL/6J-Dnm1Ftfl) 		convulsive seizures J:163311
tonic-clonic seizures J:163311
Dnm1Ftfl/Dnm1tm1.2Frk
(involves: 129 * C57BL/6J * FVB) 		seizures J:235711
Dnm1Ftfl/Dnm1tm2.2Frk
(involves: 129 * C57BL/6J * FVB) 		seizures J:235711
Dnmt3atm1b(KOMP)Wtsi/Dnmt3a+
(C57BL/6N-Dnmt3atm1b(KOMP)Wtsi/J) 		convulsive seizures J:211773
Drd1tm2Jcd/Drd1+
Tg(Camk2a-cre)2Gsc/0
(involves: 129S4/SvJae * FVB/N) 		seizures J:120070
Drd1tm2Jcd/Drd1+
Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S4/SvJae * BALB/c * CD-1 * FVB/N) 		myoclonus J:120582
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:65767
Dscamdel17/Dscamdel17
(involves: BALB/cByJ * C57BL/6J) 		seizures J:129238
Dstdt-33J/Dstdt-33J
(129S1/Sv) 		seizures J:61053
Dyrk1aem1Kzy/Dyrk1a+
(C57BL/6J-Dyrk1aem1Kzy) 		environmentally induced seizures J:259596
Ecpasem1Plch/Ecpasem1Plch
(C57BL/6-Ecpasem1Plch) 		increased susceptibility to pharmacologically induced seizures J:282974
Eef1a2em1Abb/Eef1a2em1Abb
(C57BL/6JCrl-Eef1a2em1Abb) 		sporadic seizures J:296080
Eef1dtm1.2Mkma/Eef1dtm1.2Mkma
(B6J.B6N(Cg)-Eef1dtm1.2Mkma) 		audiogenic seizures J:288930
tonic-clonic seizures J:288930
Efhc1tm1Kzy/Efhc1+
(B6.129P2-Efhc1tm1Kzy) 		increased susceptibility to pharmacologically induced seizures J:145858
myoclonus J:145858
Efhc1tm1Kzy/Efhc1tm1Kzy
(B6.129P2-Efhc1tm1Kzy) 		increased susceptibility to pharmacologically induced seizures J:145858
myoclonus J:145858
Eif2ak3tm1Dron/Eif2ak3+
Tg(GFAP-tTA)110Pop/0
Tg(tetO-Ifng)184Pop/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * Swiss Webster) 		tonic seizures J:99655
Eif2b4tm1.1Vdk/Eif2b4+
Eif2b5tm1.1Vdk/Eif2b5tm1.1Vdk
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
Eif2b4tm1.1Vdk/Eif2b4tm1.1Vdk
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
Eif2b4tm1.1Vdk/Eif2b4tm1.1Vdk
Eif2b5tm1.1Vdk/Eif2b5+
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
Eif2b4tm1.1Vdk/Eif2b4tm1.1Vdk
Eif2b5tm1.1Vdk/Eif2b5tm1.1Vdk
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
Eif2b5tm1.1Vdk/Eif2b5tm1.1Vdk
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
El1EL/?
(involves: DBA/2J * EL) 		seizures J:11381
El1EL/?
(involves: ABP/LeJ * EL) 		seizures J:11381
El2EL/?
(involves: ABP/LeJ * EL) 		seizures J:11381
El2EL/El2EL
(involves: ABP/LeJ * EL/Suz) 		seizures J:114157
El3EL/SuzSeyFrkJ/El3ABP/LeJ
(involves: ABP/LeJ * EL/Suz) 		seizures J:30433
El3EL/SuzSeyFrkJ/El3EL/SuzSeyFrkJ
(involves: ABP/LeJ * EL/Suz) 		seizures J:30433
El4EL/SuzSeyFrkJ/El4EL/SuzSeyFrkJ
(involves: DDY/Jcl * EL/Suz) 		seizures J:30433
El4EL/SuzSeyFrkJ/El4EL/SuzSeyFrkJ
(involves: ABP/LeJ * EL/Suz) 		seizures J:114157, J:30433
El5DDY/Jcl/El5EL/SuzSeyFrkJ
(involves: DDY/Jcl * EL/Suz) 		seizures J:30433
El5EL/SuzSeyFrkJ/El5EL/SuzSeyFrkJ
(involves: DDY/Jcl * EL/Suz) 		seizures J:30433
El6DDY/Jcl/El6DDY/Jcl
(involves: DDY/Jcl * EL/Suz) 		seizures J:30433
Elavl3tm1.1Rbd/Elavl3+
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1)) 		abnormal spike wave discharge J:188326
Elavl3tm1.1Rbd/Elavl3tm1.1Rbd
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1)) 		abnormal spike wave discharge J:188326
nonconvulsive seizures J:188326
Elfn1tm1(KOMP)Vlcg/Elfn1tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		seizures J:209758
Elfn1tm1.1Jaru/Elfn1tm1.1Jaru
(involves: C57BL/6) 		environmentally induced seizures J:226212
increased susceptibility to pharmacologically induced seizures J:226212
Elfn2tm1(KOMP)Vlcg/Elfn2tm1(KOMP)Vlcg
(C57BL/6NTac-Elfn2tm1(KOMP)Vlcg) 		audiogenic seizures J:286127
increased susceptibility to pharmacologically induced seizures J:286127
ElnvEL/SuzSeyFrkJ/ElnvEL/SuzSeyFrkJ
(involves: ABP/LeJ * EL/Suz) 		seizures J:114157
Elovl4tm1Wked/Elovl4tm1Wked
Tg(IVL-Elovl4)#Wked/0
Tg(KRT14-Elovl4)#Mpag/0
(involves: 129 * C57BL/6) 		seizures J:277065
Elp1tm1Id/Elp1tm1.1Id
Tg(Hsp70-1-cre)6Arge/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA) 		audiogenic seizures J:188923
environmentally induced seizures J:188923
Elp1tm1Id/Elp1tm1Id
Tg(Hsp70-1-cre)6Arge/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA) 		audiogenic seizures J:188923
environmentally induced seizures J:188923
Eml1heco/Eml1heco
(involves: NOR) 		increased susceptibility to pharmacologically induced seizures J:208031
myoclonus J:208031
seizures J:208031
Emx1tm1(cre)Krj/?
Kcnq2tm1.1Avtz/Kcnq2tm1.1Avtz
(involves: 129S2/SvPas * C57BL/6) 		tonic-clonic seizures J:208109
Emx1tm1(cre)Krj/Emx1+
Numbtm1Ynj/Numbtm1Ynj
Numbltm1Wmz/Numbltm1Wmz
(involves: 129S2/SvPas * 129X1/SvJ * CD-1) 		sporadic seizures J:87149
Emx1tm1.1(cre)Ito/Emx1+
Scn1atm2.1Kzy/Scn1atm2.1Kzy
Tg(Slc32a1-cre)65Kzy/0
(involves: 129P2/OlaHsd * C57BL/6) 		convulsive seizures J:202863
Emx1tm1.1(cre)Ito/Emx1+
Tg(Gfap-GFAP*R239H)60TMIke/0
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:139349
epf/epf
(Not Specified) 		seizures J:6309
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J) 		myoclonus J:76688
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Gvh/Xpatm1Hvs
Tg(Camk2a-cre)1Szi/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA) 		seizures J:179808
Exq1A/J/?
(involves: A/J * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:54925
Exq1C57BL/6J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
Faim2tm1Dgen/Faim2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(B6.129S4-Fcgr2btm1Ttk) 		abnormal seizure response to electrical stimulation J:169028
maximal tonic hindlimb extension seizures J:169028
tonic-clonic seizures J:169028
Fgf7tm1Efu/Fgf7tm1Efu
(B6.129-Fgf7tm1Efu) 		increased susceptibility to pharmacologically induced seizures J:161954
Fgf13tm1Jom/Fgf13+
(C57BL/6-Fgf13tm1Jom) 		abnormal kindling response J:222555
environmentally induced seizures J:222555
seizures J:222555
Fgf14tm1Dor/Fgf14tm1Dor
(129S6/SvEvTac-Fgf14tm1Dor) 		increased susceptibility to pharmacologically induced seizures J:77806
Fgf14tm1Dor/Fgf14tm1Dor
(B6.129S6-Fgf14tm1Dor) 		increased susceptibility to pharmacologically induced seizures J:77806
Fgf22tm1Dgen/Fgf22tm1Dgen
(B6.Cg-Fgf22tm1Dgen) 		decreased susceptibility to pharmacologically induced seizures J:161954
Fmr1tm1Cgr/Y
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		audiogenic seizures J:127792
Fmr1tm1Cgr/Y
(involves: 129P2/OlaHsd * FVB) 		convulsive seizures J:113177
tonic-clonic seizures J:113177
Fmr1tm1Cgr/Y
(either: FVB.129P2(B6)-Fmr1tm1Cgr/J or FVB;129P2(B6)-Fmr1tm1Cgr/J) 		audiogenic seizures J:85912
Fmr1tm1Cgr/Y
Grm5tm1Rod/Grm5+
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		audiogenic seizures J:127792
Fmr1tm1Rbd/Y
(B6.129-Fmr1tm1Rbd) 		audiogenic seizures J:155593
Fosbtm1Brv/Fosbtm1Brv
(involves: 129S2/SvPas) 		tonic-clonic seizures J:33415
Fosbtm1Meg/Fosbtm1Meg
(involves: 129S4/SvJae * 129X1/SvJ) 		abnormal seizure response to electrical stimulation J:110995
Foxa2tm1Khk/Foxa2tm1Khk
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA) 		seizures J:70409
Fyntm1Sor/Fyn+
Tg(Camk2a-Fyn-531)1Nko/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		tonic seizures J:59490
Fyntm1Yik/Fyntm1Yik
(involves: C57BL/6 * CBA) 		audiogenic seizures J:23384
Fzd9tm1Sjp/Fzd9tm1Sjp
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:99893
G6pc1tm1Jyc/G6pc1tm1Jyc
(involves: 129S4/SvJae) 		seizures J:33212
G6pc1tm2.2Jyc/G6pc1tm2.2Jyc
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N) 		seizures J:155990
Gabbr1tm1Bet/Gabbr1tm1Bet
(BALB/c-Gabbr1tm1Bet) 		absence seizures J:70558
audiogenic seizures J:70558
clonic seizures J:70558
seizures J:70558
tonic-clonic seizures J:70558
Gabbr1tm1Pngl/Gabbr1tm1Pngl
(involves: 129P2/OlaHsd * C57BL/6J) 		sporadic seizures J:70254
tonic-clonic seizures J:70254
Gabbr2tm1Arca/Gabbr2tm1Arca
(involves: 129P2/OlaHsd) 		seizures J:146953
tonic-clonic seizures J:146953
Gabbr2tm1Bet/Gabbr2tm1Bet
(BALB/c-Gabbr2tm1Bet) 		clonic seizures J:103989
Gabra1tm1.1Geh/Gabra1+
(D2.129(Cg)-Gabra1tm1.1Geh) 		abnormal spike wave discharge J:186685
absence seizures J:186685
Gabra1tm1.1Geh/Gabra1+
(B6.129(Cg)-Gabra1tm1.1Geh) 		abnormal spike wave discharge J:186685, J:227437
absence seizures J:186685, J:227437
increased susceptibility to pharmacologically induced seizures J:227437
myoclonus J:227437
seizures J:227437
tonic-clonic seizures J:227437
Gabra1tm1.1Mjga/Gabra1+
(B6J.Cg-Gabra1tm1.1Mjga) 		abnormal spike wave discharge J:227437
absence seizures J:227437
increased susceptibility to pharmacologically induced seizures J:227437
myoclonus J:227437
seizures J:227437
tonic-clonic seizures J:227437
Gabra1tm1.1Uru/Gabra1tm1.1Uru
(either: 129X1.129P2-Gabra1tm1.1Uru or B6.129P2-Gabra1tm1.1Uru) 		increased susceptibility to pharmacologically induced seizures J:75895
Gabrb3tm1Geh/Gabrb3tm1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		seizures J:39801
Gabrb3tm2.1Geh/Gabrb3tm2.1Geh
Tg(Camk2a-cre)T29-1Stl/?
(involves: 129 * BALB/c * C57BL/6 * SJL) 		absence seizures J:127877
Gabrb3tm2.1Uru/Gabrb3tm2.1Uru
(B6J.129S6(Cg)-Gabrb3tm2.1Uru) 		increased susceptibility to pharmacologically induced seizures J:228332
Gabrdtm1.1Jmag/Gabrd+
Gad2tm2(cre)Zjh/Gad2+
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased susceptibility to pharmacologically induced seizures J:203336
Gabrdtm1Geh/Gabrdtm1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		absence seizures J:64288
Gabrg2tm1.2Rmac/Gabrg2+
(involves: C57BL/6 * C57BL/6J * SJL) 		absence seizures J:306976
febrile seizures J:306976
increased susceptibility to pharmacologically induced seizures J:306976
myoclonus J:306976
seizures J:306976
tonic-clonic seizures J:306976
Gabrg2tm1Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6) 		absence seizures J:127120
increased susceptibility to pharmacologically induced seizures J:127120
Gabrg2tm1Spet/Gabrg2+
(involves: 129 * BALB/cJ * C57BL/6 * DBA/2J) 		absence seizures J:127120
Gabrg2tm1Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ) 		increased susceptibility to pharmacologically induced seizures J:194736
Gabrg2tm1Spet/Gabrg2tm1Spet
n-TRtct5m1J/n-TRtct5m1J
(B6.129(Cg)-Gabrg2tm1Spet/Frk) 		abnormal spike wave discharge J:297745
Gabrg2tm1Spet/Gabrg2tm1Spet
n-TRtct5m1J/n-TRtct5m1J
Tg(n-TRtct5)574Slac/0
(B6.129(Cg)-Gabrg2tm1Spet Tg(n-TRtct5)574Slac) 		abnormal spike wave discharge J:297745
Gabrg2tm2Lusc/Gabrg2tm2Lusc
Tg(Camk2a-cre)2834Lusc/0
(involves: 129P2/OlaHsd * 129X1/SvJ) 		seizures J:86221
Gabrg2tm2Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to pharmacologically induced seizures J:194196
Gabrg2tm2Spet/Gabrg2+
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-cre)LC1Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:194736
Gad2tm1Bae/Gad2tm1Bae
(involves: 129X1/SvJ * C57BL/6) 		seizures J:44638
Gad2tm1Bae/Gad2tm1Bae
(involves: 129X1/SvJ * NOD) 		seizures J:44638
Gad2tm1Miya/Gad2tm1Miya
(NOD.129P2-Gad2tm1Miya) 		seizures J:88785
Gad2tm1Oba/Gad2+
(involves: C57BL/6 * CBA) 		seizures J:37576
Gad2tm1Oba/Gad2tm1Oba
(involves: C57BL/6 * CBA) 		myoclonus J:62320
seizures J:62320, J:37576
tonic-clonic seizures J:62320
Galtm1Wyn/Galtm1Wyn
(129P2-Galtm1Wyn) 		increased susceptibility to pharmacologically induced seizures J:77625
seizures J:77625
Galctwi/Galctwi
Glb1tm1Adz/Glb1+
(involves: 129P2/OlaHsd * C57BL/6J * CE/J) 		seizures J:63197
Gantm1Yany/Gantm1Yany
(Not Specified) 		seizures J:108239
Gba1tm1Karl/Gba1tm1Karl
Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		seizures J:127108
Gba1tm2Karl/Gba1tm2Karl
Tg(KRT14-cre)8Brn/?
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		seizures J:127108
Gdi1tm1Ytk/Gdi1tm1Ytk
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * C57BL/6 * DBA/2)) 		increased susceptibility to pharmacologically induced seizures J:65258
Gfaptm2Mes/Gfap+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:114689
Gfaptm2Mes/Gfap+
Tg(GFAP)10Mes/0
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N) 		seizures J:114689
Gfra2tm1Msa/Gfra2tm1Msa
(either: (involves: 129S1/Sv * 129S2/SvHsd * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NHsd)) 		decreased kindling response J:53284
Gjb1tm1Kwi/Y
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		tonic seizures J:219594
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi
Gjb1tm1Kwi/Gjb1tm1Kwi
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		seizures J:83885
sporadic seizures J:83885
tonic seizures J:83885, J:219594
Gjc2tm1Paul/Gjc2tm1Paul
Gjb1tm1Kwi/Gjb1tm1Kwi
(involves: 129/Sv * C57BL/6) 		tonic seizures J:84338
Glra1nmf11/Glra1nmf11
(C57BL/6J-Glra1nmf11/J) 		seizures J:78134
Glra1spd-ot9J/Glra1spd-ot9J
(B6.Cg-Glra1spd-ot9J/GrsrJ) 		tonic-clonic seizures J:234690
Glra1tm1.1Geh/Glra1tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:177105
Glra1tm1Rah/Glra1tm1Rah
(involves: 129X1/SvJ * C57BL/6J) 		seizures J:85341
Glra1tm2.1Geh/Glra1tm2.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:177106
Glra3tm1Dgen/Glra3tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Glultm1.1Ncd/Glultm1.1Ncd
Emx1tm1(cre)Krj/Emx1+
(B6.Cg-Glultm1.1Ncd Emx1tm1(cre)Krj) 		seizures J:272643
Gna11tm1Soff/Gna11tm1Soff
Gnaqtm2Soff/Gnaqtm2Soff
Tg(Camk2a-cre)1Gsc/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N) 		clonic seizures J:111559
seizures J:111559
tonic-clonic seizures J:111559
Gnao1em1Rneu/Gnao1+
(involves: C57BL/6J * C57BL/6NCrl) 		increased kindling response J:271137
Gnao1tm1Ejne/Gnao1tm1Ejne
(involves: 129S4/SvJae * C57BL/6) 		sporadic seizures J:39013
Gnao1tm2.1Rneu/Gnao1+
(B6.129S-Gnao1tm2.1Rneu) 		abnormal kindling response J:216850
Gnao1tm2Rneu/Gnao1+
(involves: 129S1/Sv * C57BL/6J) 		abnormal spike wave discharge J:197965
Gnb5flr/Gnb5flr
Myo5aflr/Myo5aflr
(involves: C57BL/6J * C57BL/10J * CBA/Ca) 		convulsive seizures J:61324
Gng3tm1.1Rbs/Gng3tm1.1Rbs
(involves: FVB/N) 		audiogenic seizures J:92791
convulsive seizures J:92791
Gng3tm1.1Rbs/Gng3tm1.1Rbs
(involves: C57BL/6J * FVB/N) 		audiogenic seizures J:92791
Gng3tm1.1Rbs/Gng3tm1.1Rbs
Gng7tm1Lex/Gng7tm1Lex
(B6.Cg-Gng7tm1Lex Gng3tm1.1Rbs) 		environmentally induced seizures J:182775
seizures J:182775
tonic-clonic seizures J:182775
Gpx4tm2Marc/Gpx4tm2Marc
Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		convulsive seizures J:139668
Gria2tm1Rsp/Gria2+
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:30145
tonic-clonic seizures J:30145
Gria2tm2.1Rsp/Gria2+
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:51845
Gria2tm2Rsp/Gria2+
Tg(Camk2a-cre)1Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		seizures J:111689
Gria2tm2Rsp/Gria2+
Tg(Gria2*586N)238.2Rsp/0
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:51845
Gria3tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
Gria3tm1Dgen/Gria3tm1Dgen
Gria4spkw1/Gria4spkw1
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J) 		absence seizures J:135814
Gria4spkw1/Gria4+
(involves: C3H/HeJ * C3HeB/FeJ) 		absence seizures J:135814
Gria4spkw1/Gria4spkw1
(involves: C3H/HeJ * C57BL/6J) 		absence seizures J:98638
Gria4spkw1/Gria4spkw1
(C3H/HeJ) 		absence seizures J:135814
Gria4spkw1/Gria4spkw1
(involves: C3H/HeJ * C3HeB/FeJ) 		absence seizures J:135814
Gria4spkw1/Gria4spkw1
(C3Fe.C3-Gria4spkw1) 		abnormal spike wave discharge J:228536
Gria4spkw1/Gria4spkw1
Pcnx2em1Frk/Pcnx2em1Frk
(C3Fe.C3-Pcnx2em1Frk Gria4spkw1) 		abnormal spike wave discharge J:228536
Gria4spkw1/Gria4spkw1
Pcnx2em5Frk/Pcnx2em5Frk
(C3Fe.C3-Pcnx2em5Frk Gria4spkw1) 		abnormal spike wave discharge J:228536
Gria4spkw1/Gria4spkw1
spkw2C3H/HeJ/spkw2C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		absence seizures J:98638
Gria4spkw1/Gria4tm1Dgen
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J) 		absence seizures J:135814
Gria4tm1Dgen/Gria4+
(involves: 129P2/OlaHsd * C57BL/6J) 		absence seizures J:135814
Gria4tm1Dgen/Gria4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal seizure response to pharmacological agent J:101679
Gria4tm1Dgen/Gria4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		absence seizures J:135814
Grik2tm1Bvis/Grik2tm1Bvis
(129S/Sv-Grik2tm1Bvis) 		increased susceptibility to pharmacologically induced seizures J:107698
Grik2tm1Sfh/Grik2tm1Sfh
(involves: 129S1/Sv * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:46932
Grik4tm1(cre)Mim/Grik4+
Grin1tm1Mim/Grin1tm1Mim
(involves: C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:144994
tonic-clonic seizures J:144994
Grik5tm1Dgen/Grik5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Grin1tm1Blt/Grin1tm1Blt
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:62289
Grin2atm1Rsp/Grin2atm1Rsp
(involves: 129S1/Sv * 129X1/SvJ) 		decreased kindling response J:45446
Grm5tm1Dgen/Grm5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:82809
increased susceptibility to pharmacologically induced seizures J:82809
Grm7m1Btlr/Grm7m1Btlr
(C57BL/6J-Grm7m1Btlr) 		convulsive seizures J:224658
Grm7tm1Betz/Grm7tm1Betz
(B6.129P2-Grm7tm1Betz) 		increased susceptibility to pharmacologically induced seizures J:138831
Grm7tm1Dgen/Grm7tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Grm7tm1Nak/Grm7tm1Nak
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:52411
Gsg1ltm1.2Tern/Gsg1ltm1.2Tern
(C57BL/6J-Gsg1ltm1.2Tern) 		increased susceptibility to pharmacologically induced seizures J:301313
Gt(ROSA)26Sortm1(CAG-Bgeo,-Insc/GFP)Jakn/Gt(ROSA)26Sortm1(CAG-Bgeo,-Insc/GFP)Jakn
Tg(Nes-cre)1Wmz/0
(involves: C57BL/6) 		seizures J:178712
Gt(ROSA)26Sortm1(Crh)Jde/Gt(ROSA)26Sortm1(Crh)Jde
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL) 		abnormal seizure response to pharmacological agent J:140968
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+
Tg(Plp1-cre/ERT)3Pop/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		seizures J:234435
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sor+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * C57BL/6) 		seizures J:256652
hael/hael
(C3.Cg-H2p hael/GrsrJ) 		tonic seizures J:231653
Hc1/Hc1
Tg(APPswe,PSEN1dE9)85Dbo/0
(D2.Cg-Tg(APPswe,PSEN1dE9)85Dbo) 		convulsive seizures J:227541
Hcn2ap/Hcn2+
(DW/Pas-Hcn2ap) 		abnormal spike wave discharge J:146530
absence seizures J:146530
increased susceptibility to pharmacologically induced seizures J:146530
Hcn2ap/Hcn2ap
(DW/Pas-Hcn2ap) 		abnormal spike wave discharge J:146530
absence seizures J:146530
tonic-clonic seizures J:146530
Hcn2tm1Ldw/Hcn2tm1Ldw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		absence seizures J:81398
Hcrtr1tm1Dgen/Hcrtr1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Hdac4Gt(OST361114)Lex/Hdac4Gt(OST361114)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal spike wave discharge J:152466
convulsive seizures J:152466
environmentally induced seizures J:152466
tonic seizures J:152466
Helttm1Wrst/Helttm1Wrst
(B6.Cg-Helttm1Wrst) 		seizures J:119562
tonic-clonic seizures J:119562
Hexatm1Grv/Hexatm1Grv
(involves: 129P2/Ola * C57BL/6J) 		convulsive seizures J:88460
Hexatm1Rlp/Hexatm1Rlp
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129S4/SvJae * C57BL/6) 		sporadic seizures J:36305
Hexbtm1Grv/Hexbtm1Grv
(either: (involves: 129P2/Ola * C57BL/6J) or (involves: 129S1/Sv * 129X1/SvJ * C57L/6J)) 		abnormal seizure response to electrical stimulation J:30899
Hnrnph2em1Jpat/Y
(C57BL/6J-Hnrnph2em1Jpat) 		audiogenic seizures J:338313
Hnrnph2em1Jpat/Hnrnph2+
(C57BL/6J-Hnrnph2em1Jpat) 		audiogenic seizures J:338313
Hnrnph2em2Jpat/Y
(C57BL/6J-Hnrnph2em2Jpat) 		audiogenic seizures J:338313
Hnrnph2em2Jpat/Hnrnph2em2Jpat
(C57BL/6J-Hnrnph2em2Jpat) 		audiogenic seizures J:338313
Hnrnpuem1Frk/Hnrnpu+
(Not Specified) 		maximal tonic hindlimb extension seizures J:342579
hpc/hpc
(involves: STOCK Hps6ru f) 		clonic seizures J:64096
Hpdlem1Jgg/Hpdlem1Jgg
(C57BL/6-Hpdlem1Jgg) 		seizures J:334229
Hprt1tm1(CAG-Glra3*)Jcme/Y
Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:207981
Hprt1tm1Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:44728
seizures J:44728
Hprt1tm1Detl/Hprt1tm1Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:44728
seizures J:44728
Hprt1tm2Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
Hprt1tm2Detl/Hprt1tm2Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
Hprt1tm4Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
Hprt1tm4Detl/Hprt1tm4Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
Hprt1tm6Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
Hprt1tm6Detl/Hprt1tm6Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
Hrh2tm1Yfks/Hrh2tm1Yfks
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal seizure response to electrical stimulation J:102252
Htr1atm1Toth/Htr1atm1Toth
(involves: 129P2/OlaHsd * Black Swiss) 		increased susceptibility to pharmacologically induced seizures J:66581
Htr2ctm1Jke/Y
(B6.129-Htr2ctm1Jke) 		tonic-clonic seizures J:147514
Htr2ctm1Jke/Y
Tg(Pomc1-cre)16Lowl/0
(B6.Cg-Htr2ctm1Jke Tg(Pomc1-cre)16Lowl) 		tonic-clonic seizures J:147514
Htr2ctm1Jul/Y
(either: (involves: 129S2/SvPas * C57BL/6J * DBA/2) or (involves: 129S4/SvJae * C57BL/6J * DBA/2)) 		increased susceptibility to pharmacologically induced seizures J:24339
sporadic seizures J:24339
tonic seizures J:24339
tonic-clonic seizures J:24339
Htr2ctm2Jke/Y
Tg(Zp3-cre)93Knw/0
(involves: 129X1/SvJ * C57BL/6J) 		seizures J:207704
Htr4tm1Comp/Htr4tm1Comp
(129/Sv-Htr4tm1Comp) 		increased susceptibility to pharmacologically induced seizures J:87451
Htr7tm1Wtkn/Htr7tm1Wtkn
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal seizure response to electrical stimulation J:124549
increased susceptibility to pharmacologically induced seizures J:124549
Htra2mnd2/Htra2mnd2
(involves: C3H/HeJ * C57BL/6J * CAST/Ei) 		seizures J:50420
Htttm1Detl/Htttm1Detl
(involves: 129P2/OlaHsd * C57BL/6J) 		tonic-clonic seizures J:67074
Htttm1Mem/Htttm6Mem
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * Swiss Webster) 		environmentally induced seizures J:260244
Htttm2Detl/Htttm2Detl
(involves: 129P2/OlaHsd * C57BL/6J) 		tonic-clonic seizures J:67074, J:123681
Htttm6Mem/Htttm8Mem
(involves: 129S1/Sv * 129X1/SvJ * Swiss Webster) 		seizures J:72915
Igsf9tm1Kln/Igsf9tm1Kln
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:209586
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6J * CE/J) 		seizures J:63197
Impa1Rgsc01846/Impa1Rgsc01846
(B6NJcl.B6JJcl-Impa1Rgsc01846/Rbrc) 		seizures J:250420
Impa1tm1Lex/Impa1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:157887
Iqsec2em1Csbg/Y
(C57BL/6NHsd-Iqsec2em1Csbg) 		sporadic seizures J:284750
Iqsec2em1Csbg/Iqsec2+
(C57BL/6NHsd-Iqsec2em1Csbg) 		sporadic seizures J:284750
Iqsec2em1Frk/Y
(involves: C3HeB/FeJ * C57BL/6NJ) 		convulsive seizures J:284762
decreased susceptibility to induction of seizure by inducing agent J:284762
decreased susceptibility to pharmacologically induced seizures J:284762
Iqsec2em1Frk/Iqsec2+
(involves: C3HeB/FeJ * C57BL/6NJ) 		decreased susceptibility to induction of seizure by inducing agent J:284762
Itgavtm2Hyn/Itgavtm2.1Hyn
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB * SJL) 		convulsive seizures J:94376
seizures J:94376
Itpr1opt/Itpr1opt
(involves: C57BLKS) 		seizures J:50383, J:28829, J:37547
Itpr1tm1Tno/Itpr1tm1Tno
(involves: 129S4/SvJae * C57BL/6) 		seizures J:30633
tonic-clonic seizures J:30633
jb/jb
(involves: C3HeB/FeJ * C57BL/6J) 		convulsive seizures J:39707
Juntm2.1Wag/Juntm2.1Wag
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:53481
Kcna1mceph/Kcna1mceph
(BALB/cByJ-Kcna1mceph/J) 		convulsive seizures J:89910, J:119491
seizures J:89910
tonic-clonic seizures J:89910
Kcna1tm1Tem/Kcna1+
(involves: 129S7/SvEvBrd * various) 		increased susceptibility to pharmacologically induced seizures J:47349
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd * various) 		increased susceptibility to pharmacologically induced seizures J:47349
seizures J:47349
tonic-clonic seizures J:47349
Kcna1tm1Tem/Kcna1tm1Tem
(C3Fe.129S7-Kcna1tm1Tem) 		seizures J:206598
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd * C57BL/6) 		seizures J:77281
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd * BALB/cByJ * C3HeB/FeJ) 		convulsive seizures J:119491
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd) 		myoclonus J:164091
seizures J:164091
tonic-clonic seizures J:164091
Kcna2tm1Tem/Kcna2+
(C3Fe.129S7-Kcna2tm1Tem) 		increased susceptibility to pharmacologically induced seizures J:131735
Kcna2tm1Tem/Kcna2tm1Tem
(involves: 129S7/SvEvBrd * C57BL/6) 		tonic seizures J:131735
Kcna2tm1Tem/Kcna2tm1Tem
(C3Fe.129S7-Kcna2tm1Tem) 		increased susceptibility to pharmacologically induced seizures J:131735
tonic seizures J:131735
Kcna2tm1Tem/Kcna2tm1Tem
(involves: 129S7/SvEvBrd) 		seizures J:130097
Kcna4tm1Lndn/Kcna4tm1Lndn
(involves: 129S4/SvJae * C57BL/6) 		seizures J:48415
Kcnab2tm1Kmc/Kcnab2tm1Kmc
(involves: 129S7/SvEvBrd * C57BL/6) 		sporadic seizures J:75891
Kcnc1tm1Joho/Kcnc1tm1Joho
Kcnc3tm1Echa/Kcnc3tm1Echa
(involves: 129/Sv * C57BL/6) 		myoclonus J:71179
Kcnc2tm1Rudy/Kcnc2tm1Rudy
(B6.129S1-Kcnc2tm1Rudy) 		increased susceptibility to pharmacologically induced seizures J:66730
myoclonus J:66730
seizures J:66730
sporadic seizures J:66730
tonic-clonic seizures J:66730
Kcnh3tm1.2Tije/Kcnh3+
(involves: C57BL/6) 		abnormal spike wave discharge J:165296
Kcnh3tm1.2Tije/Kcnh3tm1.2Tije
(involves: C57BL/6) 		abnormal spike wave discharge J:165296
increased susceptibility to pharmacologically induced seizures J:165296
nonconvulsive seizures J:165296
Kcnip1tm1Zhzh/Kcnip1tm1Zhzh
(involves: C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:227383
Kcnj6tm1Stf/Kcnj6tm1Stf
(involves: 129S1/Sv * 129X1/SvJ) 		environmentally induced seizures J:38206
increased susceptibility to pharmacologically induced seizures J:38206
tonic-clonic seizures J:38206
Kcnj6tm1Stf/Kcnj6tm1Stf
Kcnj9tm1Kwn/Kcnj9tm1Kwn
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:77047
Kcnj6wv/Kcnj6wv
(C57BL/6J-Kcnj6wv) 		tonic-clonic seizures J:30520
Kcnj10tm1Kdmc/Kcnj10tm1Kdmc
Tg(GFAP-cre)1Kdmc/?
(involves: 129S6/SvEvTac * C3H * C57BL/6 * C57BL/6J * SJL) 		tonic-clonic seizures J:126082
Kcnj11tm1Sse/Kcnj11tm1Sse
(involves: 129P2/OlaHsd) 		convulsive seizures J:69832
myoclonus J:69832
tonic-clonic seizures J:69832
Kcnk2tm1Lzd/Kcnk2tm1Lzd
(involves: 129 * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:91531
Kcnmb4tm1Rwa/Kcnmb4tm1Rwa
(involves: 129X1/SvJ * C57BL/6) 		nonconvulsive seizures J:103931
Kcnq2Nmf134/Kcnq2+
(C57BL/6J-Kcnq2Nmf134/J) 		abnormal seizure response to electrical stimulation J:82238
Kcnq2Nmf134/Kcnq2+
(C57BL/6J-Kcnq2Nmf134) 		abnormal seizure response to electrical stimulation J:136510
increased susceptibility to pharmacologically induced seizures J:136510
Kcnq2Nmf134/Kcnq2+
Scn1atm1.1Aesc/Scn1a+
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:170734
tonic-clonic seizures J:170734
Kcnq2Nmf134/Kcnq2+
Tg(Eno2-Scn2a1*)Q54Mm/0
(involves: C57BL/6J * SJL/J) 		seizures J:136510
tonic-clonic seizures J:136510
Kcnq2Nmf134/Kcnq2Nmf134
(C57BL/6J-Kcnq2Nmf134/J) 		abnormal seizure response to electrical stimulation J:82238
Kcnq2tm1.1Lvi/Kcnq2+
(129-Kcnq2tm1.1Lvi/Lvi) 		tonic-clonic seizures J:298666
Kcnq2tm1.1Naas/Kcnq2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal seizure response to electrical stimulation J:154582
Kcnq2tm1.1Naas/Kcnq2tm1.1Naas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		seizures J:154582
Kcnq2tm1.1Naas/Kcnq2tm1.1Naas
(B6.129-Kcnq2tm1.1Naas) 		tonic-clonic seizures J:154582
Kcnq2tm1.1Naas/Kcnq2tm1.1Naas
(FVB.129-Kcnq2tm1.1Naas) 		seizures J:154582
Kcnq2tm1Dgen/Kcnq2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Kcnq2tm1Hsa/Kcnq2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:62797
Kcnq2tm2.1Snhr/Kcnq2+
(B6.Cg-Kcnq2tm2.1Snhr) 		clonic seizures J:213443
Kcnq2tm2.1Snhr/Kcnq2tm2.1Snhr
(B6.Cg-Kcnq2tm2.1Snhr) 		clonic seizures J:213443
Kcnq2tm3.1Snhr/Kcnq2+
(B6.Cg-Kcnq2tm3.1Snhr) 		clonic seizures J:213443
Kcnq3tm1.1Naas/Kcnq3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal seizure response to electrical stimulation J:154582
Kcnq3tm1.1Naas/Kcnq3+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		abnormal seizure response to electrical stimulation J:154582
Kcnq3tm1.1Naas/Kcnq3tm1.1Naas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		seizures J:154582
Kcnq3tm1.1Naas/Kcnq3tm1.1Naas
(B6.129-Kcnq3tm1.1Naas) 		seizures J:154582
Kcnq3tm1.1Naas/Kcnq3tm1.1Naas
(FVB.129-Kcnq3tm1.1Naas) 		seizures J:154582
Kcnt1em1Pqt/Kcnt1em1Pqt
(C57BL/6J-Kcnt1em1Pqt) 		seizures J:333512
tonic-clonic seizures J:333512
Kcnt1em8Frk/Kcnt1em8Frk
(C57BL/6NJ-Kcnt1em8Frk) 		seizures J:300699
tonic seizures J:300699
tonic-clonic seizures J:300699
Kcnt1em8Frk/Kcnt1em8Frk
(involves: 129P2/OlaHsd * C57BL/6NJ * FVB) 		seizures J:300699
Kdm1atm1Ebg/Kdm1atm1Ebg
(B6.129-Kdm1atm1Ebg) 		absence seizures J:235553
decreased susceptibility to pharmacologically induced seizures J:235553
tonic-clonic seizures J:235553
Kif5atm1.2Noh/Kif5atm1.2Noh
Tg(Syn1-cre)671Jxm/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA) 		seizures J:197666
Kif5atm1Gsn/Kif5atm2Gsn
Tg(Syn1-cre)671Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		sporadic seizures J:82911
Klk8tm1Lth/Klk8tm1Lth
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:71533
L2hgdhGt(DC0625)Wtsi/L2hgdhGt(DC0625)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:228407
Lamp5em1Lmit/Lamp5+
(C57BL/6-Lamp5em1Lmit) 		increased susceptibility to pharmacologically induced seizures J:345459
Lamp5em1Lmit/Lamp5em1Lmit
(C57BL/6-Lamp5em1Lmit) 		increased susceptibility to pharmacologically induced seizures J:345459
Letm1Gt(CC0204)Wtsi/Letm1+
(129S.129P2-Letm1Gt(CC0204)Wtsi) 		increased susceptibility to pharmacologically induced seizures J:222017
Letm1Gt(DD0926)Wtsi/Letm1+
(129S.129P2-Letm1Gt(DD0926)Wtsi) 		increased susceptibility to pharmacologically induced seizures J:222017
Lgi1tm1.1Ics/Lgi1+
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		audiogenic seizures J:182795
Lgi1tm1.1Ics/Lgi1tm1.1Ics
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		abnormal spike wave discharge J:182795
environmentally induced seizures J:182795
seizures J:182795
tonic-clonic seizures J:182795
Lgi1tm1.1Jkc/Lgi1tm1.1Jkc
Tyrc-Brd/Tyrc-Brd
(B6.Cg-Tyrc-Brd Lgi1tm1.1Jkc) 		clonic seizures J:158715
seizures J:158715
Lgi1tm1Mafu/Lgi1+
(involves: 129S6/SvEvTac * C57BL/6) 		clonic seizures J:157578
increased susceptibility to pharmacologically induced seizures J:157578
tonic seizures J:157578
Lgi1tm1Mafu/Lgi1tm1Mafu
(involves: 129S6/SvEvTac * C57BL/6) 		seizures J:157578
tonic-clonic seizures J:157578
Lgi1tm2.1Jkc/Lgi1tm2.1Jkc
Tg(CMV-cre)1Cgn/0
(involves: 129/Sv * BALB/cJ * C57BL/6) 		seizures J:269784
Lgi1tm2.1Jkc/Lgi1tm2.1Jkc
Tg(Nes-cre)1Kln/0
(involves: 129/Sv * C57BL/6 * SJL) 		seizures J:269784
Lhx6tm1Vpa/Lhx6tm2Vpa
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal spike wave discharge J:198547
environmentally induced seizures J:198547
increased susceptibility to pharmacologically induced seizures J:198547
tonic-clonic seizures J:198547
Loxl1tm1.1(KOMP)Vlcg/Loxl1tm1.1(KOMP)Vlcg
(B6N(Cg)-Loxl1tm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
Lpoem1Zlu/Lpoem1Zlu
(involves: C57BL/6 * SJL) 		seizures J:307289
Lrrc4btm1Lex/Lrrc4btm1Lex
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:276446
m154Asp/m154Asp+
Tg(Rr291-lacZ)#Mekk/0
(involves: C57BL/6J * FVB/N) 		sporadic seizures J:136795
Mafgtm1Jeng/Mafgtm1Jeng
Mafktm1Jeng/Mafk+
(involves: 129S1/Sv * 129X1/SvJ) 		myoclonus J:81813
Magtm1.1(KOMP)Vlcg/Magtm1.1(KOMP)Vlcg
(C57BL/6N-Magtm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
Mapk10tm1Flv/Mapk10tm1Flv
(involves: 129S1/Sv) 		decreased susceptibility to pharmacologically induced seizures J:43658
Mapttm1Hnd/Mapt+
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mapttm1Hnd/Mapt+
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mapttm1Hnd/Mapttm1Hnd
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mapttm1Hnd/Mapttm1Hnd
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mbnl2tm1.1Sws/Mbnl2+
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:218010
Mbnl2tm1.1Sws/Mbnl2tm1.1Sws
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:218010
tonic-clonic seizures J:218010
Mbpjve/Mbpjve
(involves: C57BL/6J) 		absence seizures J:221049
environmentally induced seizures J:221049
tonic seizures J:221049
Mbpshi-mld+/Mbpshi-mld+
(involves: C3H/HeJ * C57BL/6J * MDB/Dt) 		convulsive seizures J:1873
Mbpshi-mld/Mbpshi-mld
(involves: MDB/Dt) 		sporadic seizures J:5917
Mbpshi/Mbpshi
(involves: C3H * ICR * SWV) 		audiogenic seizures J:6578
environmentally induced seizures J:6578
tonic seizures J:6578
Mbpshi/Mbpshi
Tg(Thy1-YFP)HJrs/0
(involves: C3HeB/Fe * C57BL/6 * CBA * SWV) 		increased susceptibility to pharmacologically induced seizures J:158545
Mc2rtm1Dgen/Mc2rtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82809
Mcoln3Va/Mcoln3+
(involves: C57BL * C57BR) 		tonic seizures J:13133
Mcoln3Va/Mcoln3Va
(involves: C57BL * C57BR) 		tonic seizures J:13133
Mecp2em1Jlzn/Y
(C57BL/6-Mecp2em1Jlzn) 		environmentally induced seizures J:296009
seizures J:296009
Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		seizures J:166851
Mecp2tm1.1Dhy/Y
(C57BL/6N-Mecp2tm1.1Dhy) 		seizures J:209069
Mecp2tm1.1Irsf/Mecp2+
(involves: 129S2/SvPas * C57BL/6) 		tonic-clonic seizures J:220859
Mecp2tm1.1Joez/Y
(B6.129-Mecp2tm1.1Joez) 		seizures J:181311
Mecp2tm1.1Jtc/Mecp2+
(involves: 129S6/SvEvTac * C57BL/6) 		tonic-clonic seizures J:209637
Mecp2tm1Bird/Y
Ssttm2.1(cre)Zjh/Sst+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		seizures J:228740
tonic-clonic seizures J:228740
Mecp2tm1Hzo/Y
(involves: 129S7/SvEvBrd * C57BL/6J) 		seizures J:78009
Mecp2tm1Pplt/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		sporadic seizures J:137513
Mecp2tm3Meg/Y
(B6.129-Mecp2tm3Meg) 		increased susceptibility to pharmacologically induced seizures J:204723
Mir128-2tm1.1Ans/Mir128-2tm1.1Ans
Tg(Camk2a-cre)2Gsc/0
(involves: BALB/cJ * C57BL/6J * FVB/N) 		seizures J:205260
Mir128-2tm1.1Ans/Mir128-2tm1.1Ans
Tg(Drd1-cre)EY262Gsat/0
(involves: BALB/cJ * C57BL/6J * FVB/N) 		seizures J:205260
Mir128-2tm1.2Ans/Mir128-2tm1.2Ans
(involves: BALB/cJ * C57BL/6J) 		seizures J:205260
Mir145atm1Eno/Mir145atm1Eno
(involves: 129S/SvEv * C57BL/6) 		seizures J:152458
Mirc32tm1.2Eno/Mirc32tm1.2Eno
(involves: 129S/SvEv * C57BL/6) 		seizures J:152458
Mldhrtm1Zhgn/Mldhrtm1Zhgn
Tg(GFAP-cre)25Mes/0
(involves: FVB/N) 		seizures J:303725
Msx2tm1Rilm/Msx2tm1Rilm
(either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6J)) 		tonic seizures J:61509
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J) 		clonic seizures J:89429
increased susceptibility to pharmacologically induced seizures J:89429
tonic-clonic seizures J:89429
Mt3tm1Rpa/Mt3tm1Rpa
(involves: 129S7/SvEvBrd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:38222
Mtmr9tm1Wum/Mtmr9+
(Not Specified) 		seizures J:336167
Myo3btm1b(EUCOMM)Hmgu/Myo3btm1b(EUCOMM)Hmgu
(C57BL/6N-Myo3btm1b(EUCOMM)Hmgu/J) 		convulsive seizures J:211773
Myo5ad-15H/Myo5ad-15H
(Not Specified) 		seizures J:13409
Myo5ad-l32J/Myo5ad-l32J
(B6.Cg-Myo5ad-l32J/GrsrJ) 		clonic seizures J:169210
Myo5ad-l/Myo5ad-l
(involves: C57BL) 		clonic seizures J:12978
Myo5ad-n2Btlr/Myo5ad-n2Btlr
(C57BL/6J-Myo5ad-n2Btlr) 		myoclonus J:133120
Myo5ad-n/Myo5ad-n
(B10.D2-H2d/nSnJ) 		clonic seizures J:171603
Myo5ad-nBtlr/Myo5ad-nBtlr
(C57BL/6J-Myo5ad-nBtlr) 		myoclonus J:133119
Myo9aem1Atuf/Myo9aem1Atuf
(C57BL/6J-Myo9aem1Atuf) 		seizures J:302901
Myrftm1Barr/Myrftm1Barr
Cnptm1(cre)Kan/Cnp+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		seizures J:150563
Myrftm1Barr/Myrftm1Barr
Olig2tm2(TVA,cre)Rth/Olig2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6) 		seizures J:150563
n-TRtct5m1J/n-TRtct5m1J
(C57BL/6J) 		abnormal seizure response to electrical stimulation J:297745
abnormal seizure response to pharmacological agent J:297745
n-TRtct5tm1.1Slac/n-TRtct5tm1.1Slac
(C57BL/6J-n-TRtct5tm1.1Slac) 		abnormal seizure response to electrical stimulation J:297745
abnormal seizure response to pharmacological agent J:297745
n-TRtct5tm2.1Slac/n-TRtct5tm2.1Slac
(C57BL/6NJ-n-TRtct5tm2.1Slac) 		abnormal seizure response to pharmacological agent J:297745
Napbtm1Bros/Napbtm1Bros
(Not Specified) 		seizures J:167753
Ncdntm2Afu/Ncdntm2Afu
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		seizures J:99914
Ndufs4tm1.1Rpa/Ndufs4tm1.1Rpa
(involves: 129S4/SvJaeSor) 		environmentally induced seizures J:161393
seizures J:161393
Ndufs4tm1Rpa/Ndufs4tm1Rpa
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL) 		environmentally induced seizures J:161393
seizures J:161393
tonic-clonic seizures J:161393
nerv/nerv
(BALB/c-nerv) 		seizures J:227974
Neto1tm1Mci/Neto1tm1Mci
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:145953
Neu1tm1Adz/Neu1tm1Adz
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI)) 		myoclonus J:76937
Neurod1tm1Mjts/Neurod1tm1Mjts
(involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J) 		seizures J:59932
sporadic seizures J:59932
tonic-clonic seizures J:59932
Neurod2tm1Tap/Neurod2+
(involves: 129/Sv * C57BL/6) 		sporadic seizures J:69606
tonic-clonic seizures J:69606
Neurod2tm1Tap/Neurod2tm1Tap
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:69606
Nexmiftm1(KOMP)Wtsi/Y
(B6J.B6N-Nexmiftm1(KOMP)Wtsi) 		seizures J:283395
Nf1tm1Par/Nf1+
Ptentm1Hwu/Pten+
Trp53tm1Elee/Trp53+
Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N) 		seizures J:134611
Nf1tm1Par/Nf1+
Ptentm1Hwu/Pten+
Trp53tm1Tyj/Trp53+
Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S2/SvPas * 129S4/SvJae * 129X1/SvJ * FVB/N) 		seizures J:134611
Nf1tm1Par/Nf1+
Trp53tm1Elee/Trp53+
Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N) 		seizures J:134611
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		increased susceptibility to pharmacologically induced seizures J:218959
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:210491
abnormal seizure response to pharmacological agent J:210491
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
Gys1tm1c(EUCOMM)Wtsi/Gys1+
Tg(Nes-cre)1Kag/?
(involves: C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:210491
abnormal seizure response to pharmacological agent J:210491
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
Gys1tm1c(EUCOMM)Wtsi/Gys1tm1c(EUCOMM)Wtsi
Tg(Nes-cre)1Kag/?
(involves: C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:210491
abnormal seizure response to pharmacological agent J:210491
Nhlrc1tm1.2Geno/Nhlrc1tm1.2Geno
(involves: 129S2/SvPas * C57BL/6J) 		abnormal spike wave discharge J:181559
myoclonus J:181559
Nid1tm1Dong/Nid1tm1Dong
(involves: 129P2/OlaHsd) 		sporadic seizures J:80843
Nmf31/Nmf31
(BALB/cByJ-Nmf31/J) 		myoclonus J:87349
Nmf31/Nmf31+
(BALB/cByJ-Nmf31/J) 		minimal clonic seizures J:78134
nmf88/nmf88
(C57BL/6J-nmf88/J) 		abnormal seizure response to electrical stimulation J:82238
nmf391/nmf391
(C57BL/6J-nmf391/J) 		myoclonus J:87349
Nos1tm1Plh/Nos1tm1Plh
(B6.129S4-Nos1tm1Plh) 		abnormal seizure response to inducing agent J:107964
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau) 		increased susceptibility to pharmacologically induced seizures J:107300
Nos3tm1Plh/Nos3tm1Plh
(B6.129S4-Nos3tm1Plh) 		abnormal seizure response to inducing agent J:107964
Npas4tm1Meg/Npas4tm1Meg
(involves: C57BL/6) 		seizures J:143367
Npas4tm1Ooe/Npas4tm1Ooe
(involves: 129/Sv * C57BL/6) 		myoclonus J:145569
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:124729
Npytm1Rpa/Npytm1Rpa
(involves: 129S7/SvEvBrd) 		increased susceptibility to pharmacologically induced seizures J:33261
sporadic seizures J:33261
Npytm2Rpa/Npytm2Rpa
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:104699
Nr4a3tm1Omc/Nr4a3tm1Omc
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:93320
tonic-clonic seizures J:93320
Nrcamtm2e.1(KOMP)Wtsi/Nrcamtm2e.1(KOMP)Wtsi
(C57BL/6N-Nrcamtm2e.1(KOMP)Wtsi/J) 		convulsive seizures J:211773
Nrp2tm1.2Mom/Nrp2+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ) 		environmentally induced seizures J:166116
increased susceptibility to pharmacologically induced seizures J:166116
myoclonus J:166116
seizures J:166116
Nrp2tm1.2Mom/Nrp2tm1.2Mom
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ) 		environmentally induced seizures J:166116
increased susceptibility to pharmacologically induced seizures J:166116
myoclonus J:166116
seizures J:166116
Ntrk2tm1Jom/Ntrk2+
Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR) 		decreased kindling response J:91467
Ntrk2tm1Jom/Ntrk2tm1Jom
Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR) 		decreased kindling response J:91467
nur8/nur8
(Not Specified) 		seizures J:85113
nur33/nur33
(Not Specified) 		myoclonus J:89098
Nur37/Nur37+
(Not Specified) 		seizures J:89098
Oprd1tm1Dgen/Oprd1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Otcspf/Y
(involves: C3H/HeJ * C57BL/6J) 		tonic-clonic seizures J:31237
Otud7aem1Cpsc/Otud7aem1Cpsc
(C57BL/6J-Otud7aem1Cpsc) 		abnormal spike wave discharge J:259730
Otx1tm1Asim/Otx1tm1Asim
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		convulsive seizures J:35640
nonconvulsive seizures J:35640
Otx1tm1Asim/Otx1tm1Asim
(involves: 129P2/OlaHsd) 		seizures J:52989
P2rx6tm1Dgen/P2rx6tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:82809
Pacsin1tm1.1Bqu/Pacsin1tm1.1Bqu
(Not Specified) 		tonic-clonic seizures J:180017
Pahm1Btlr/Pahm1Btlr
(C57BL/6J-Pahm1Btlr) 		audiogenic seizures J:152890
environmentally induced seizures J:152890
Panx1tm1.1Fama/Panx1tm1.1Fama
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:177671
Panx1tm1a(KOMP)Wtsi/Panx1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		decreased susceptibility to pharmacologically induced seizures J:177671
Pcmt1tm1Scl/Pcmt1tm1Scl
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:40967
tonic-clonic seizures J:40967
Pcmt1tm1Shs/Pcmt1tm1Shs
(involves: 129P2/OlaHsd * C57BL/6) 		clonic seizures J:46228
convulsive seizures J:46228
myoclonus J:46228
tonic-clonic seizures J:46228
Pcntm239Asp/Pcnt+
Tg(Rr291-lacZ)#Mekk/0
(involves: C57BL/6J * FVB/N) 		sporadic seizures J:136795
Pcntm275Asp/Pcnt+
Tg(Rr291-lacZ)#Mekk/0
(involves: C57BL/6J * FVB/N) 		sporadic seizures J:136795
Pde8atm1Dgen/Pde8atm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82809
Pdgfratm6Sor/Pdgfratm6Sor
(either: 129S4/SvJaeSor-Pdgfratm6Sor or (involves: 129S4/SvJaeSor * C57BL/6J)) 		seizures J:73817
Pdyntm1(cre)Czer/Pdyn+
(B6.Cg-Pdyntm1(cre)Czer) 		increased susceptibility to pharmacologically induced seizures J:122651
Pdyntm1(cre)Czer/Pdyntm1(cre)Czer
(B6.Cg-Pdyntm1(cre)Czer) 		increased susceptibility to pharmacologically induced seizures J:122651
Phf6em1Azbi/Y
(B6.Cg-Phf6em1Azbi) 		increased susceptibility to pharmacologically induced seizures J:271089
Pis1A/J/Pis1A/J
(C57BL/6J-Chr 10A/J/NaJ) 		increased susceptibility to pharmacologically induced seizures J:118211
Pis2A/J/Pis2A/J
(C57BL/6J-Chr 18A/J/NaJ) 		increased susceptibility to pharmacologically induced seizures J:118211
PitpnaGt(OST1152)Lex/PitpnaGt(OST1152)Lex
(involves: 129S5/SvEvBrd) 		seizures J:85204
Pitpnatm1Vab/Pitpnatm1Vab
(involves: 129S7/SvEvBrd) 		seizures J:85204
Plaurtm1Mlg/Plaurtm1Mlg
(B6.Cg-Plaurtm1Mlg) 		increased susceptibility to pharmacologically induced seizures J:81735
myoclonus J:81735
Plcb1tm1Hssh/Plcb1tm1Hssh
(Not Specified) 		convulsive seizures J:43077
increased susceptibility to pharmacologically induced seizures J:43077
Plcl1tm1Mh/Plcl1tm1Mh
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:92956
seizures J:92956
Plp1jp-4J/Y
(involves: C3H/HeJ * C57BL/6J) 		seizures J:41569
Plp1jp-msd/Y
(involves: C57BL/10Sn * BALB/cJ) 		seizures J:5170
Plp1jp-rsh/Y
(involves: C57BL/6NCrl) 		seizures J:88023
Plp1jp/Y
(Not Specified) 		environmentally induced seizures J:288
tonic-clonic seizures J:13141
Plppr4tm1Roni/Plppr4tm1Roni
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:157318
tonic-clonic seizures J:157318
Plppr5em2Gpt/Plppr5em2Gpt
(C57BL/6-Plppr5em2Gpt) 		increased susceptibility to pharmacologically induced seizures J:324004
Pmp22tm1Ueli/Pmp22tm1Ueli
(involves: 129S/SvEv) 		convulsive seizures J:29517
Pmp22Tr/?
(Not Specified) 		seizures J:7222
Pmp22Tr/Pmp22+
(Not Specified) 		convulsive seizures J:13038
Ppargc1atm1Brsp/Ppargc1atm1Brsp
(involves: 129/Sv * C57BL/6 * FVB/N) 		myoclonus J:93896
Ppp1r9btm1Jfe/Ppp1r9btm1Jfe
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:77284
Ppt1tm1Aj/Ppt1tm1Aj
(involves: 129S4/SvJae * C57BL/6) 		myoclonus J:95522
seizures J:95522
Ppt1tm1Hof/Ppt1tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J) 		myoclonus J:72931
Prickle1em1Yzou/Prickle1+
(C57BL/6-Prickle1em1Yzou) 		increased susceptibility to pharmacologically induced seizures J:321396
Prickle1m1Ingm/Prickle1+
(involves: C57BL/6) 		abnormal seizure response to electrical stimulation J:169136
Prickle1m2Ingm/Prickle1+
(C57BL/6-Prickle1m2Ingm) 		abnormal seizure response to electrical stimulation J:169136
Prickle1tm1Nue/Prickle1+
(B6.Cg-Prickle1tm1Nue) 		abnormal seizure response to electrical stimulation J:169136
Prickle2tm1Nue/Prickle2+
(B6.Cg-Prickle2tm1Nue) 		abnormal seizure response to electrical stimulation J:169136
Prickle2tm1Nue/Prickle2tm1Nue
(B6.Cg-Prickle2tm1Nue) 		abnormal seizure response to electrical stimulation J:169136
increased susceptibility to pharmacologically induced seizures J:169136
Prkab1Gt(RRR454)Byg/Prkab1Gt(RRR454)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:146618
Prnptm1Cwe/Prnptm1Cwe
Tg(Prnp*)#Rgab/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		myoclonus J:183170
Prrt2tm1a(KOMP)Wtsi/Prrt2tm1a(KOMP)Wtsi
(C57BL/6N-Atm1Brd Prrt2tm1a(KOMP)Wtsi/Wtsi) 		audiogenic seizures J:237823
increased susceptibility to pharmacologically induced seizures J:237823
Psaptm1Suz/Psaptm1Suz
(involves: 129P2/OlaHsd) 		seizures J:113052
tonic seizures J:33477
Psaptm2Suz/Psaptm2Suz
(involves: 129S/SvEv * C57BL/6J) 		seizures J:78223
psrt1R/psrt1R
(involves: BJR) 		seizures J:73982
psrt2R/psrt2R
(involves: BJR) 		seizures J:73982
Ptentm1Rdp/Pten+
Trp53tm1Brn/Trp53tm1Brn
Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N) 		seizures J:140704
Ptentm2Mak/Ptentm2Mak
Tg(Eno2-cre)39Jme/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		sporadic seizures J:109635
Ptentm2Mak/Ptentm2Mak
Tg(Gfap-cre)1Sbk/0
(involves: 129P2/OlaHsd) 		abnormal spike wave discharge J:149829
seizures J:75500
tonic-clonic seizures J:149829
Ptentm2Mak/Ptentm2Mak
Tg(Nes-cre/ERT2,-ALPP)1Sbk/0
(involves: 129P2/OlaHsd) 		seizures J:237990
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6;129P2-Ptgs2tm1Unc/Tac) 		increased susceptibility to pharmacologically induced seizures J:141610
tonic-clonic seizures J:141610
Ptprotm1Dgen/Ptprotm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Puratm1Kkh/Pura+
(involves: 129) 		seizures J:85759
Puratm1Kkh/Puratm1Kkh
(involves: 129) 		seizures J:85759
Qkie5/Qkie5
(B6.101Rl-Qkie5) 		seizures J:102038
Qkie5/Qkiqk-k2
(involves: 101/Rl * C57BL/6J * CBA/Ca) 		seizures J:102038
Qkie5/Qkiqk-kt1
(involves: 101/Rl * C57BL/6J) 		seizures J:102038
Qkiqk-shk/Qkiqk-shk
(involves: 129 * C57BL/6) 		tonic seizures J:220956
Qkiqk-v/Qkiqk-v
(B6C3Fe a/a-Qkiqk-v/J) 		seizures J:102038
Qkiqk-v/Qkiqk-v
(involves: C3H/Di * DBA/2J) 		tonic seizures J:13141
Rai1tm1Jrl/Rai1+
(involves: 129S/SvEvBrd * C57BL/6) 		seizures J:125089
Rai1tm1Jrl/Rai1tm1Jrl
(involves: 129S/SvEvBrd * C57BL/6) 		seizures J:125089
tonic-clonic seizures J:125089
Rbfox1tm1.1Dblk/Rbfox1+
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:176189
Rbfox1tm1.1Dblk/Rbfox1tm1.1Dblk
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:176189
seizures J:176189
tonic-clonic seizures J:176189
Rbfox3tm1a(EUCOMM)Hmgu/Rbfox3tm1a(EUCOMM)Hmgu
(B6Dnk;B6N-Rbfox3tm1a(EUCOMM)Hmgu/H) 		increased susceptibility to pharmacologically induced seizures J:234043
Rgsc73/Rgsc73+
(involves: C57BL/6JJcl * DBA/2JJcl) 		convulsive seizures J:133634
Rnd3Gt(OST364657)Lex/Rnd3Gt(OST364657)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		convulsive seizures J:172361
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/J) 		convulsive seizures J:211773
Rogditm1.2Ics/Rogditm1.2Ics
(involves: C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:344072
Ryr2tm1Slh/Ryr2+
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:235432
Ryr2tm2Amks/Ryr2+
(B6.129-Ryr2tm2Amks) 		increased susceptibility to pharmacologically induced seizures J:137696
tonic-clonic seizures J:137696
Ryr2tm2Amks/Ryr2tm2Amks
(B6.129-Ryr2tm2Amks) 		increased susceptibility to pharmacologically induced seizures J:137696
tonic-clonic seizures J:137696
S1pr2tm1Ajml/S1pr2tm1Ajml
(involves: 129S5/SvEvBrd * C57BL/6) 		seizures J:73957
tonic-clonic seizures J:73957
S1pr2tm1Ajml/S1pr2tm1Ajml
(either: (involves: 129S5/SvEvBrd) or (involves: 129S5/SvEvBrd * C57BL/6)) 		seizures J:112371
S1pr2tm1Ytak/S1pr2tm1Ytak
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:168060
Scamp5tm1Smoc/Scamp5tm1Smoc
(involves: C57BL/6J) 		audiogenic seizures J:288324
seizures J:288324
Scg5tm1Led/Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6)) 		convulsive seizures J:77510
Scn1aem1Anord/Scn1a+
(C57BL/6N-Scn1aem1Anord) 		abnormal spike wave discharge J:333350
environmentally induced seizures J:333350
increased susceptibility to pharmacologically induced seizures J:333350
Scn1aem1Anord/Scn1aem1Anord
(C57BL/6N-Scn1aem1Anord) 		environmentally induced seizures J:333350
Scn1atm1.1Aesc/Scn1a+
(involves: 129X1/SvJ * C57BL/6J * SJL) 		abnormal spike wave discharge J:161191
environmentally induced seizures J:161191
increased susceptibility to pharmacologically induced seizures J:161191
seizures J:161191
tonic seizures J:161191
tonic-clonic seizures J:161191
Scn1atm1.1Aesc/Scn1a+
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:170734
Scn1atm1.1Aesc/Scn1a+
Tg(Eno2-Scn2a1*)Q54Mm/0
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J * SJL/J) 		convulsive seizures J:170734
tonic-clonic seizures J:170734
Scn1atm1.1Aesc/Scn1atm1.1Aesc
(involves: 129X1/SvJ * C57BL/6J * SJL) 		clonic seizures J:161191
environmentally induced seizures J:161191
maximal tonic hindlimb extension seizures J:161191
seizures J:161191
tonic seizures J:161191
Scn1atm1.1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:121969
Scn1atm1.1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J) 		convulsive seizures J:209093
increased susceptibility to pharmacologically induced seizures J:209093
Scn1atm1.1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C3HeB/FeJ) 		environmentally induced seizures J:260796
seizures J:260796
Scn1atm1.1Swl/Scn1a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JNarl) 		environmentally induced seizures J:221045
tonic-clonic seizures J:221045
Scn1atm1.1Swl/Scn1atm1.1Swl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JNarl) 		tonic-clonic seizures J:221045
Scn1atm1Kea/Scn1a+
((C57BL/6J x 129S6/SvEvTac-Scn1atm1Kea)F1) 		seizures J:203040
Scn1atm1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:121969
Scn1atm1Kzy/Scn1atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:121969
tonic seizures J:121969
tonic-clonic seizures J:121969
Scn1atm1Wac/Scn1a+
(B6.129-Scn1atm1Wac) 		seizures J:113149
Scn1atm1Wac/Scn1a+
(involves: 129S1/Sv * 129X1/SvJ * FVB/NJ) 		abnormal spike wave discharge J:129998
increased susceptibility to pharmacologically induced seizures J:129998
tonic-clonic seizures J:129998
Scn1atm1Wac/Scn1a+
Scn8amed-jo/Scn8a+
(involves: 129 * C57BL/6J * DBA/2WyDi * FVB/NJ) 		abnormal spike wave discharge J:129998
Scn1atm1Wac/Scn1atm1Wac
(B6.129-Scn1atm1Wac) 		clonic seizures J:113149
convulsive seizures J:113149
seizures J:113149
Scn1atm2.1Kzy/Scn1a+
Tg(Pvalb-cre)1Tama/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		convulsive seizures J:202863
Scn1atm2.1Kzy/Scn1a+
Tg(Slc32a1-cre)65Kzy/0
(involves: 129P2/OlaHsd * C57BL/6) 		convulsive seizures J:202863
Scn1atm2.1Kzy/Scn1atm2.1Kzy
Tg(Pvalb-cre)1Tama/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		convulsive seizures J:202863
Scn1atm2.1Kzy/Scn1atm2.1Kzy
Tg(Slc32a1-cre)65Kzy/0
(involves: 129P2/OlaHsd * C57BL/6) 		convulsive seizures J:202863
Scn1atm2.1Wac/Scn1a+
Tg(I12b-cre)1Jlr/0
(involves: C57BL/6J * CD-1) 		clonic seizures J:189897
environmentally induced seizures J:189897
seizures J:189897
tonic-clonic seizures J:189897
Scn1atm2.2Kzy/Scn1a+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		convulsive seizures J:202863
Scn1atm2.2Kzy/Scn1atm2.2Kzy
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		convulsive seizures J:202863
Scn1btm1.1Bion/Scn1b+
(Not Specified) 		environmentally induced seizures J:163771
Scn1btm1.1Bion/Scn1btm1.1Bion
(Not Specified) 		environmentally induced seizures J:163771
seizures J:163771
tonic-clonic seizures J:163771
Scn1btm1Isom/Scn1btm1Isom
(involves: 129X1/SvJ * C57BL/6) 		seizures J:90136
Scn1btm2.1Isom/Scn1btm2.1Isom
(involves: 129X1/SvJ * C57BL/6) 		seizures J:128713
Scn2btm1Isom/Scn2btm1Isom
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82050
Scn5atm1Clhh/Scn5a+
(involves: 129 * 129S/SvEv * C57BL/6J) 		seizures J:127879
Scn8a7J/Scn8a7J
(involves: BALB/cByJ * C57BL/6J) 		myoclonus J:87349
Scn8a8J/Scn8a8J
(involves: C3HeB/FeJ * C57BL/6J) 		abnormal spike wave discharge J:147199
Scn8a8J/Scn8a+
(involves: C3HeB/FeJ * C57BL/6J) 		abnormal spike wave discharge J:147199
Scn8aem1Mm/Scn8a+
(involves: C57BL/6J * SJL) 		seizures J:207931
Scn8amed-jo/Scn8a+
(B6.D2-Scn8amed-jo/J) 		abnormal spike wave discharge J:147199
decreased susceptibility to pharmacologically induced seizures J:170734, J:129998
Scn8amed/Scn8a+
(C3Fe.Cg-Scn8amed/J) 		abnormal spike wave discharge J:147199
decreased susceptibility to pharmacologically induced seizures J:129998
Scn9atm1.1Naas/Scn9atm1.1Naas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal seizure response to electrical stimulation J:154118
minimal clonic seizures J:154118
Scn9atm1.1Naas/Scn9atm1.1Naas
(B6.129-Scn9atm1.1Naas) 		abnormal kindling response J:154118
Seh1ltm1Lzha/Seh1ltm1Lzha
Olig1tm1(cre)Rth/Olig1+
(involves: 129S4/SvJae * C57BL/6) 		seizures J:276253
Senp2tm1Eyeh/Senp2tm1Eyeh
(Not Specified) 		audiogenic seizures J:217910
convulsive seizures J:217910
Serpine2tm1Dmn/Serpine2tm1Dmn
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:40953
Sez6tm1.1Sest/Sez6tm1.1Sest
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:132725
Sgcetm1Ygl/Sgce+
(involves: 129S2/SvPas) 		myoclonus J:180682
Sgcetm1Ygl/Sgcetm1Ygl
(involves: 129S2/SvPas * 129S4/SvJaeSor * BALB/c * C57BL/6) 		myoclonus J:101332
Sh3gl1tm1Pdc/Sh3gl1tm1Pdc
Sh3gl2tm1Pdc/Sh3gl2+
Sh3gl3tm1.2Itl/Sh3gl3tm1.2Itl
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * FVB/N * SJL) 		seizures J:178947
Sh3gl1tm1Pdc/Sh3gl1tm1Pdc
Sh3gl2tm1Pdc/Sh3gl2tm1Pdc
(involves: 129) 		seizures J:178947
Sh3rf2tm1Zhxu/Sh3rf2+
(C57BL/6-Sh3rf2tm1Zhxu) 		seizures J:270945
Shank3tm1.1Cya/Shank3tm1.1Cya
(B6.Cg-Shank3tm1.1Cya) 		decreased susceptibility to pharmacologically induced seizures J:281328
Shank3tm2Gfng/Shank3tm2Gfng
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:171113
Shhtm2Amc/Shhtm2Amc
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		seizures J:102950
Sicd1C57BL/6J/Sicd1C57BL/6J
(FVB.B6-(D18Mit141-D18Mit25)) 		increased susceptibility to pharmacologically induced seizures J:122922
sims/sims
(B6.Cg-sims/GrsrJ) 		audiogenic seizures J:161505
sims/sims+
(B6.Cg-sims/GrsrJ) 		environmentally induced seizures J:161505
Slc1a2tm1.1Ncd/Slc1a2tm1.1Ncd
Tg(Nes-cre)1Kln/0
(B6.Cg-Slc1a2tm1.1Ncd Tg(Nes-cre)1Kln) 		seizures J:207177
Slc1a2tm1.1Pros/Slc1a2tm1.1Pros
Tg(GFAP-cre/ERT2)13Kdmc/0
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6) 		seizures J:221590
Slc1a2tm1Kta/Slc1a2tm1Kta
(involves: 129P2/OlaHsd * C57BL/6) 		convulsive seizures J:40984
increased susceptibility to pharmacologically induced seizures J:40984
Slc1a3tm1Kta/Slc1a3tm1Kta
(involves: 129P2/OlaHsd) 		abnormal kindling response J:58180
increased susceptibility to pharmacologically induced seizures J:58180
seizures J:58180
Slc2a1tm1Dcdv/Slc2a1+
(involves: 129S6/SvEvTac * C57BL/6J) 		sporadic seizures J:108250
Slc4a3tm1Cahb/Slc4a3tm1Cahb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:104157
Slc4a10tm1.1Cahb/Slc4a10tm1.1Cahb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:131058
Slc6a5trsl/Slc6a5trsl
(C57BL/6J-Slc6a5trsl/GrsrJ) 		tonic seizures J:235637
Slc6a11tm1Dgen/Slc6a11+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
Slc7a8tm1Dgen/Slc7a8tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
Slc7a10tm1Dgen/Slc7a10tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		myoclonus J:100127
seizures J:100127
tonic-clonic seizures J:100127
Slc9a1swe/Slc9a1swe
(SJL/J-Slc9a1swe/J) 		seizures J:43429
tonic-clonic seizures J:43429
Slc9a1swe/Slc9a1swe
(B6.SJL-Slc9a1swe) 		seizures J:43429
tonic-clonic seizures J:43429
Slc9a1swe/Slc9a1swe
(involves: C57BL/6J * SJL/J) 		absence seizures J:43429
seizures J:43429
tonic-clonic seizures J:43429
Slc9a1tm1Smb/Slc9a1tm1Smb
(involves: 129X1/SvJ * Black Swiss) 		convulsive seizures J:54705
Slc9a6tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Slc10a4tm1Tigm/Slc10a4tm1Tigm
(involves: 129S/SvEvBrd) 		abnormal spike wave discharge J:196996
increased susceptibility to pharmacologically induced seizures J:196996
seizures J:196996
Slc12a5tm1Dlp/Slc12a5+
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:113307
Slc12a5tm1Dlp/Slc12a5tm1Dlp
(involves: 129 * C57BL/6J) 		tonic-clonic seizures J:113307
Slc12a5tm1Hsav/Slc12a5tm2Hsav
(involves: 129S1/Sv * 129S2/SvPasHsd * 129X1/SvJ * C57BL/6J * C57BL/6JOlaHsd) 		increased susceptibility to pharmacologically induced seizures J:101079
Slc12a6tm1Tjj/Slc12a6tm1Tjj
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:86183
Slc13a1tm1Mark/Slc13a1+
(involves: 129T2/SvEms * C57BL/6J) 		clonic seizures J:86561
Slc13a1tm1Mark/Slc13a1tm1Mark
(involves: 129T2/SvEms * C57BL/6J) 		clonic seizures J:86561
Slc17a5tm1Lex/Slc17a5tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		environmentally induced seizures J:158444
tonic-clonic seizures J:158444
Slc17a8tm1Edw/Slc17a8tm1Edw
(involves: 129P2/OlaHsd * C57BL/6) 		nonconvulsive seizures J:132704
Slc18a3tm1Mca/Slc18a3tm1Mca
(involves: 129S4/SvJae * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:136620
Slc25a12Gt(OST123999)Lex/Slc25a12Gt(OST123999)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		convulsive seizures J:101164
Slc25a46atc/Slc25a46atc
(B6.Cg-Slc25a46atc) 		tonic-clonic seizures J:242350
Slc32a1tm2(cre)Lowl/Slc32a1tm2(cre)Lowl
(either: B6J.129S6(FVB)-Slc32a1tm2(cre)Lowl or (involves: 129S6/SvEvTac * C57BL/6J * FVB/N)) 		increased kindling response J:308516
tonic-clonic seizures J:308516
Slc37a4tm1Jyc/Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6) 		seizures J:86005
Slitrk3tm1Jaru/Slitrk3tm1Jaru
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:232385
seizures J:232385
Smarcb1tm2Sho/Smarcb1tm2Sho
Trp53tm1Brn/Trp53tm1Brn
Tg(GFAP-cre)#Gtm/0
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA) 		seizures J:226786
Snap25tm1.1Bark/Snap25tm1.1Bark
(B6.Cg-Snap25tm1.1Bark) 		seizures J:142096
Snap25tm1Bark/Snap25tm1Bark
(B6.Cg-Snap25tm1Bark) 		seizures J:142096
Snap25tm1Mtaka/Snap25tm1Mtaka
(B6N.129P2-Snap25tm1Mtaka) 		convulsive seizures J:177870
Snap25tm2Mcw/Snap25tm2Mcw
(involves: C57BL/6J) 		myoclonus J:94005
Snap91tm1.1Tmar/Snap91tm1.1Tmar
(involves: 129S6/SvEvTac * C57BL/6NTac) 		tonic-clonic seizures J:228428
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J * DBA/2J) 		seizures J:73998, J:98007
Sox1tm1Vep/Sox1tm1Vep
(either: (involves: 129/Sv * 129S/SvEv) or (involves: 129S/SvEv * MF1)) 		seizures J:46636
Sox1tm1Vep/Sox1tm2Vep
Sox2tm1Vep/Sox2+
(involves: 129S/SvEv) 		seizures J:99610
Sox1tm2Vep/Sox1tm2Vep
(Not Specified) 		seizures J:99610
Sox2tm2Skn/Sox2tm3Skn
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J) 		nonconvulsive seizures J:92063
Sox10gt/Sox10gt
(involves: HYIII/LeJ) 		sporadic seizures J:7723
Sox10gt/Sox10gt
(involves: C57BL/6 * GT/Le) 		seizures J:216967
sps/sps
(involves: C57BL/10Bg) 		convulsive seizures J:12239, J:32781
Sptbn2Gt(XK442)Byg/Sptbn2Gt(XK442)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		clonic seizures J:158494
St3gal4tm1.1Bsi/St3gal4tm1.1Bsi
(B6J.B6N-St3gal4tm1.1Bsi) 		decreased kindling response J:217104
Stamtm1Sug/Stamtm1Sug
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:69504
Stx1btm1.1Sud/Stx1btm1.1Sud
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		seizures J:138035
Sult4a1em1Uab/Sult4a1em1Uab
(C57BL/6J-Sult4a1em1Uab) 		absence seizures J:280143
Sult4a1em2Uab/Sult4a1em2Uab
(C57BL/6J-Sult4a1em2Uab) 		absence seizures J:280143
Sumf1Gt(RST760)Byg/Sumf1Gt(RST760)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:120146
Sv2atm1Baj/Sv2a+
(Not Specified) 		seizures J:59073
Sv2atm1Baj/Sv2atm1Baj
(Not Specified) 		seizures J:59073
Sv2atm1Baj/Sv2atm1Baj
(involves: 129X1/SvJ * C57BL/6) 		seizures J:70828
Sv2atm1Baj/Sv2atm1Baj
Sv2btm1Baj/Sv2btm1Baj
(involves: 129 * C57BL/6) 		seizures J:70828
Sv2atm1Sud/Sv2atm1Sud
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:59180
Sv2atm1Sud/Sv2atm1Sud
Sv2btm1Sud/Sv2btm1Sud
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:59180
Sv2btm1Baj/Sv2btm1Baj
(involves: 129 * C57BL/6) 		seizures J:70828
Syn1tm1Pggd/Syn1tm1Pggd
(involves: 129) 		abnormal seizure response to electrical stimulation J:29086
Syn1tm1Pggd/Syn1tm1Pggd
Syn2tm1Pggd/Syn2tm1Pggd
Syn3tm1Pggd/Syn3tm1Pggd
(involves: 129 * 129P2/OlaHsd * 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:175256
tonic-clonic seizures J:175256
Syn1tm1Sud/Syn1tm1Sud
(involves: 129S7/SvEvBrd) 		convulsive seizures J:15701
Syn1tm1Sud/Syn1tm1Sud
Syn2tm1Sud/Syn2tm1Sud
(involves: 129S7/SvEvBrd) 		convulsive seizures J:26920
Syn2tm1Pggd/Syn2tm1Pggd
(Not Specified) 		seizures J:202031
Syn2tm1Sud/Syn2tm1Sud
(involves: 129S7/SvEvBrd) 		convulsive seizures J:26920
Syngap1tm1Rlh/Syngap1+
(involves: 129S1/Sv * 129X1/SvJ) 		audiogenic seizures J:193208
increased susceptibility to pharmacologically induced seizures J:193208
Syngr1tm1Sud/Syngr1tm1Sud
Syngr3tm1Sud/Syngr3tm1Sud
Synprtm1Sud/Synprtm1Sud
Syptm1Sud/Syptm1Sud
(Not Specified) 		seizures J:156812
Synj1tm1Pdc/Synj1tm1Pdc
(involves: 129S1/Sv * C57BL/6) 		convulsive seizures J:58087
Szs1C57BL/6J/Szs1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
seizures J:38888
Szs1DBA/2J/Szs1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
seizures J:38888
Szs1DBA/2J/Szs1DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs1DBA/2J/Szs1DBA/2J
(involves: B6.D2-Mtv7a/Ty * C57BL/6J) 		abnormal seizure response to electrical stimulation J:89732
Szs2C57BL/6J/Szs2C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:38888
Szs2C57BL/6J/Szs2DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:38888
Szs5DBA/2J/?
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
Szs6C57BL/6J/?
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
Szs7DBA/2J/?
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs8DBA/2J/Szs8C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs8DBA/2J/Szs8DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs9C57BL/6J/Szs9DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs9DBA/2J/Szs9DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs10C57BL/6J/Szs10C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs10C57BL/6J/Szs10DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs11C57BL/6J/Szs11C57BL/6J
(D2.B6-(D5Mit345-D5Mit403)) 		abnormal seizure response to electrical stimulation J:129499
Szs11DBA/2J/Szs11C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs11DBA/2J/Szs11DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs11DBA/2J/Szs11DBA/2J
(B6.D2-(D5Mit75-D5Mit403)) 		abnormal seizure response to electrical stimulation J:129499
Szs12DBA/2J/Szs12C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs12DBA/2J/Szs12DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs13DBA/2J/Szs13C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs13DBA/2J/Szs13DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szt1/Szt1+
(involves: BALB/cByJ * BALB/cJ * C57BL/6J) 		abnormal seizure response to electrical stimulation J:82964
abnormal seizure response to pharmacological agent J:82964
Szt1/Szt1+
(C57BL/6J-Szt1) 		abnormal seizure response to electrical stimulation J:136510
Szt1/Szt1+
Tg(Eno2-Scn2a1*)Q54Mm/0
(involves: C57BL/6J * SJL/J) 		seizures J:136510
tonic-clonic seizures J:136510
Szt2Gt(XH662)Byg/Szt2+
(involves: 129P2/OlaHsd * C57BL/6J) 		minimal clonic seizures J:150942
Szt2Gt(XH662)Byg/Szt2Gt(XH662)Byg
(129S1.129P2(B6)-Szt2Gt(XH662)Byg/FrkJ) 		maximal tonic hindlimb extension seizures J:150942
minimal clonic seizures J:150942
Szt2Gt(XH662)Byg/Szt2m1Frk
(involves: 129P2/OlaHsd * C57BL/6J) 		minimal clonic seizures J:150942
Szt2m1Frk/Szt2m1Frk
(C57BL/6J-Szt2m1Frk) 		abnormal kindling response J:150942
minimal clonic seizures J:150942
Szt2m1Frk/Szt2m1Frk
(involves: BALB/cByJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:150942
minimal clonic seizures J:150942
tonic-clonic seizures J:150942
Szv1C57BL/6J/Szv1C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
Szv2C57BL/6J/Szv2C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
Szv2C57BL/6J/Szv2DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
Szv3C57BL/6J/Szv3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:70295
Szv3DBA/2J/Szv3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:70295
Tal2tm1Thr/Tal2tm1Thr
(involves: 129 * C57BL/6) 		convulsive seizures J:65762
Tbc1d24em2Tbf/Tbc1d24em2Tbf
(C57BL/6J-Tbc1d24em2Tbf) 		tonic-clonic seizures J:273646
Tbc1d24em2Tbf/Tbc1d24em5Tbf
(C57BL/6J-Tbc1d24em2Tbf Tbc1d24em5Tbf) 		seizures J:299025
Tcf12tm2Zhu/Tcf12+
(Not Specified) 		seizures J:120411
Tectatm3.1Gpr/Tecta+
(involves: 129S/SvEv) 		audiogenic seizures J:203482
Tectatm4.1Gpr/Tecta+
(involves: 129S/SvEv) 		audiogenic seizures J:203482
Tectatm5.1Gpr/Tecta+
(involves: 129S/SvEv) 		audiogenic seizures J:203482
Teftm1Schb/Teftm1Schb
(involves: 129S2/SvPas) 		absence seizures J:90854
seizures J:90854
Tg(AGT)2-5Afu/0
(involves: C57BL/6) 		convulsive seizures J:130455
Tg(APPswe,PSEN1dE9)85Dbo/0
(B6.Cg-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax) 		convulsive seizures J:227541
Tg(APPswe,PSEN1dE9)85Dbo/0
(D2.Cg-Tg(APPswe,PSEN1dE9)85Dbo) 		convulsive seizures J:227541
Tg(ATN1*)Q129Stsu/0
(involves: 129S/SvEv * C57BL/6J) 		absence seizures J:144379
Tg(C9orf72)500Lpwr/0
(FVB/NJ-Tg(C9orf72)500Lpwr) 		seizures J:239579
Tg(CAG-cre/Esr1*)5Amc/0
Ube3atm1Yelg/Ube3a+
(involves: 129P2/OlaHsd * 129S2/SvPasCrl * C57BL/6J) 		audiogenic seizures J:222400
Tg(Camk2a-Bdnf)A9Stl/0
(C57BL/6-Tg(Camk2a-Bdnf)A9Stl/J) 		psychomotor seizures J:216846
seizures J:216846
Tg(Camk2a-Crem)I15Endo/0
(involves: C3H * C57BL/6) 		abnormal kindling response J:137666
Tg(Camk2a-Crem)IIEndo/0
(C57BL/6-Tg(Camk2a-Crem)IIEndo/EndoRbrc) 		abnormal kindling response J:137666
Tg(Camk2a-Fyn-531)1Nko/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		abnormal kindling response J:59490
abnormal seizure response to electrical stimulation J:59490
increased susceptibility to pharmacologically induced seizures J:59490
tonic seizures J:59490
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-MAPT)32Lms/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT)32Lms) 		increased susceptibility to pharmacologically induced seizures J:233816
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-MAPT*A152T)L1Lms/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT*A152T)L1Lms) 		increased susceptibility to pharmacologically induced seizures J:233816
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-Mtor*)#Atai/0
(involves: C57BL/6 * DBA/2 * ICR) 		seizures J:211789
Tg(Cnp-Gpr17)1Qrlu/0
(Not Specified) 		seizures J:154602
Tg(DBH-Gal)1923Stei/0
(B6.Cg-Tg(DBH-Gal)1923Stei) 		decreased susceptibility to pharmacologically induced seizures J:77625
seizures J:77625
Tg(Eno2-PTGS2)32Pasi/0
(involves: C3H/HeNTac * C57BL/6NTac) 		seizures J:100973
tonic-clonic seizures J:100973
Tg(Eno2-Scn2a1*)Q54Mm/0
(B6.Cg-Tg(Eno2-Scn2a1*)Q54Mm) 		convulsive seizures J:170734
seizures J:136510
Tg(GFAP-cre)8Gtm/0
Tsc2tm1.1Mjg/Tsc2tm1.1Mjg
(involves: 129X1/SvJ * 129S1/Sv * C57BL/6 * CBA) 		seizures J:167241
Tg(GFAP-EFNA3)181Kln/0
(involves: C57BL/6 * FVB) 		increased susceptibility to pharmacologically induced seizures J:154648
Tg(Gfap-GFAP*R239H)60TMIke/0
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:139349
Tg(Gfap-Ifna1)12Ilc/0
(involves: BALB/c * C57BL/6J) 		seizures J:68811
Tg(Gfap-Ifna1)39Ilc/0
(involves: BALB/c * C57BL/6J) 		seizures J:68811
Tg(Gfap-Il6)G16Lms/0
Tg(Gfap-lacZ)1Lms/0
(involves: C57BL/6J * SJL) 		seizures J:125549
Tg(Gfap-Il6)G167Lms/0
(involves: C57BL/6J * SJL) 		seizures J:125549
Tg(Gfap-Il6)G167Lms/Tg(Gfap-Il6)G167Lms
(involves: C57BL/6J * SJL) 		seizures J:125549
Tg(Gfap-Il6)G369Lms/0
(involves: C57BL/6J * SJL) 		seizures J:125549
Tg(Gfap-TGFB1)64Lms/Tg(Gfap-TGFB1)64Lms
(involves: BALB/c * SJL) 		seizures J:27781
Tg(HDexon1)62Gpb/0
(involves: C57BL/6J * CBA/J) 		seizures J:36689
Tg(Lgi1*)#Mpan/0
(Not Specified) 		increased susceptibility to pharmacologically induced seizures J:154129
Tg(Lmnb1)1Yfu/0
(involves: C57BL/6J) 		abnormal spike wave discharge J:197168
clonic seizures J:197168
increased susceptibility to pharmacologically induced seizures J:197168
seizures J:197168
Tg(Mbp-Pad2)28Fgm/0
(involves: CD-1) 		convulsive seizures J:142650
Tg(Mbp-Pad2)28Fgm/Tg(Mbp-Pad2)28Fgm
(involves: CD-1) 		convulsive seizures J:142650
Tg(Mbp-SNCA)29Ema/0
(involves: C57BL/6 * DBA/2) 		seizures J:102867
Tg(MECP2)1Hzo/0
(involves: FVB) 		clonic seizures J:94407
Tg(Mov1/Tyr)OVE876BPay/Y
(FVB/N-Tg(Mov1/Tyr)OVE876BPay) 		audiogenic seizures J:167614
Tg(Mov1/Tyr)OVE876BPay/Tg(Mov1/Tyr)OVE876BPay
(FVB/N-Tg(Mov1/Tyr)OVE876BPay) 		audiogenic seizures J:167614
Tg(Pcp2-cre)2Mpin/0
Tsc2tm1.1Mjg/Tsc2tm1.2Mjg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:174327
Tg(PLP1*)4Rsj/0
(involves: CD-1) 		environmentally induced seizures J:24069
Tg(Plp1-HTT*150Q)4aXjl/0
(Not Specified) 		increased susceptibility to pharmacologically induced seizures J:221608
Tg(Plp1-Lmnb1)#Yfu/0
(involves: FVB) 		seizures J:197168
Tg(Plp)66Kan/0
Tg(Plp)72Kan/0
(involves: C57BL/6 * DBA) 		convulsive seizures J:17373
Tg(Plp)66Kan/Tg(Plp)66Kan
(involves: C57BL * DBA) 		seizures J:17373
Tg(Plp)66Kan/Tg(Plp)66Kan
(B6NCrl.Cg-Tg(Plp)66Kan) 		seizures J:156106
Tg(Prnp*)#Rgab/0
(involves: C57BL/6 * FVB/N) 		myoclonus J:183170
Tg(Prnp-ATN1)150Dbo/?
(involves: C3H * C57BL/6) 		seizures J:70362
Tg(Prnp-ATXN3)BVcg/Tg(Prnp-ATXN3)BVcg
(involves: C3H/HeJ * C57BL/6) 		seizures J:96574
Tg(Prnp-ATXN3)CVcg/Tg(Prnp-ATXN3)CVcg
(involves: C3H/HeJ * C57BL/6) 		seizures J:96574
Tg(Prnp-lacZ/ATXN10*)#Teas/0
(involves: FVB/N) 		increased susceptibility to pharmacologically induced seizures J:222081
Tg(Prnp-MAPT*)2652Gds/Tg(Prnp-MAPT*)2652Gds
(B6.Cg-Tg(Prnp-MAPT*)2652Gds) 		seizures J:244052
Tg(Prnp-TBP*)71-16Xjl/0
(FVB/N-Tg(Prnp-TBP*)71-16Xjl) 		sporadic seizures J:130775
Tg(Prnp-TBP*)71-27Xjl/0
(FVB/N-Tg(Prnp-TBP*)71-27Xjl) 		sporadic seizures J:130775
Tg(Prnp-TBP*)105Xjl/0
(FVB/N-Tg(Prnp-TBP*)105Xjl) 		sporadic seizures J:130775
Tg(Prnp-tTA)F959Sbp/0
Tg(tetO-Chrnb2*V287L)H3Gica/0
(involves: 129S7/SvEvBrd * FVB) 		seizures J:145855
Tg(Prnp-tTA)F959Sbp/?
Tg(TetO-Nfkbia*S32A*S36A)1Wcg/?
(involves: 129S7/SvEvBrd * DBA * FVB/N) 		environmentally induced seizures J:112973
Tg(RP23-65I14)1Jno/?
(involves: FVB) 		absence seizures J:146431
Tg(RP23-65I14)2Jno/?
(involves: FVB/N) 		absence seizures J:146431
Tg(Scn1a*)RH9Aesc/0
(involves: FVB/NJ) 		increased susceptibility to pharmacologically induced seizures J:150454
Tg(Shank3-EGFP)1Hzo/0
(involves: FVB/N) 		seizures J:201867
Tg(Tek-tTA)1Rwng/0
Tg(tetO-Notch4*)1Rwng/0
(involves: FVB/N) 		seizures J:139943
Tg(Thy1-APP)4Vln/0
(involves: FVB/N) 		seizures J:53800
Tg(Thy1-App*R609D*K612E)2Vln/0
(involves: C57BL * CBA/J) 		seizures J:32213
Tg(Thy1-App*R609D*K612E)4Vln/0
(involves: FVB) 		clonic seizures J:32213
myoclonus J:32213
seizures J:32213
tonic-clonic seizures J:32213
Tg(Thy1-App*R609D*K612E)4Vln/Tg(Thy1-App*R609D*K612E)4Vln
(involves: FVB) 		clonic seizures J:32213
decreased susceptibility to pharmacologically induced seizures J:32213
increased susceptibility to pharmacologically induced seizures J:32213
myoclonus J:32213
seizures J:32213
tonic-clonic seizures J:32213
Tg(Thy1-App*R609D*K612E)6Vln/0
(involves: FVB) 		clonic seizures J:32213
myoclonus J:32213
seizures J:32213
tonic-clonic seizures J:32213
Tg(Thy1-App*R609D*K612E)6Vln/Tg(Thy1-App*R609D*K612E)6Vln
(involves: FVB) 		clonic seizures J:32213
decreased susceptibility to pharmacologically induced seizures J:32213
increased susceptibility to pharmacologically induced seizures J:32213
myoclonus J:32213
seizures J:32213
tonic-clonic seizures J:32213
Tg(Thy1-APPLon)2Vln/0
(involves: FVB/N) 		seizures J:53800
Tg(Thy1-APPSw)1Vln/0
(involves: FVB/N) 		seizures J:53800
Tg(Thy1-MAPT*)1Avil/Tg(Thy1-MAPT*)1Avil
(involves: C57BL/6 * CBA) 		increased susceptibility to pharmacologically induced seizures J:201700
myoclonus J:201700
nonconvulsive seizures J:201700
seizures J:201700
tonic-clonic seizures J:201700
Tg(Thy1-SERPINI1*G392E)333Icka/0
(involves: C57BL * CD-1 * DBA) 		increased susceptibility to pharmacologically induced seizures J:144649
Tg(Thy1-SERPINI1*G392E)333Icka/Tg(Thy1-SERPINI1*G392E)333Icka
(involves: C57BL * CD-1 * DBA) 		increased susceptibility to pharmacologically induced seizures J:144649
Tg(Tk1-DPP4)27Ysj/0
(involves: C57BL/6 * FVB/N) 		convulsive seizures J:290259
Tg(UBC-Adk)1Bois/0
(B6;129P3-Adktm1Bois Tg(UBC-Adk)1Bois) 		abnormal seizure response to pharmacological agent J:105483
nonconvulsive seizures J:105483
Thrbtm1Df/Thrbtm1Df
(either: B6.129S1-Thrbtm1Df or (involves: 129S1/Sv * C57BL/6J)) 		audiogenic seizures J:103702
Tinf2tm2.2Tdl/Tinf2+
(involves: BALB/cJ * C57BL/6) 		seizures J:207367
tmgc61/tmgc61
(Mixed stock) 		decreased susceptibility to pharmacologically induced seizures J:92490
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		seizures J:112713
Tpp1tm1Dgen/Tpp1tm1Dgen
(involves: 129S1/Sv * C57BL/6) 		seizures J:101679
Tpp1tm1Plob/Tpp1tm1Plob
(involves: 129S1/Sv * C57BL/6) 		audiogenic seizures J:94884
Tppptm1.1(KOMP)Vlcg/Tppptm1.1(KOMP)Vlcg
(C57BL/6N-Tppptm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
Trim2Gt(IRESBetageo)11Pgr/Trim2Gt(IRESBetageo)11Pgr
(involves: 129/Sv * C57BL/6) 		seizures J:140337
Trim3tm1Mak/Trim3tm1Mak
(B6.129P2-Trim3tm1Mak) 		decreased susceptibility to pharmacologically induced seizures J:161372
Trp53tm1Elee/Trp53tm1Elee
Tg(GFAP-cre)25Mes/0
(involves: 129S4/SvJae * FVB/N) 		seizures J:149662
Trp53tm1Elee/Trp53tm1Tyj
Tg(GFAP-cre)25Mes/0
(involves: 129S2/SvPas * 129S4/SvJae * FVB/N) 		seizures J:149662
Trpc5tm1.1Lbi/Y
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:194590
Trpc5tm1.1Lbi/Trpc5tm1.1Lbi
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:194590
Trpm7tm1Agry/Trpm7+
(involves: 129) 		seizures J:205665
Tsc1tm1Djk/Tsc1tm1.1Djk
Tg(Syn1-cre)671Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		seizures J:121858
sporadic seizures J:121858
Tsc1tm1Djk/Tsc1tm1Djk
Tg(GFAP-cre)8Gtm/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		seizures J:116872, J:167241
Tsc1tm1Djk/Tsc1tm1Djk
Tg(GFAP-cre)#Gtm/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		seizures J:176586
Tsc2tm1.1Kcess/Tsc2tm1.1Kcess
Emx1tm1(cre)Krj/Emx1+
(involves: 129S/Sv * C57BL/6J) 		environmentally induced seizures J:195049
tsl/tsl
(CByJNarl(B6NTacTcu)-tsl) 		seizures J:275934
Tubg1tm1.1Ics/Tubg1+
(involves: C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:275532
Ty/Y
((129P3/J x NZB/BlNJ)F1) 		seizures J:13773
Tyl/Y
(involves: A/J * C57BL/6J) 		seizures J:14294
Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal seizure response to inducing agent J:54681
Ube3atm1Alb/Ube3a+
(involves: 129S7/SvEvBrd * C57BL/6) 		absence seizures J:50811
audiogenic seizures J:50811
tonic-clonic seizures J:50811
Ube3atm1Alb/Ube3a+
(involves: 129S7/SvEvBrd) 		audiogenic seizures J:50811
tonic-clonic seizures J:50811
Ube3atm1Alb/Ube3atm1Alb
(involves: 129S7/SvEvBrd * C57BL/6) 		audiogenic seizures J:50811
Ube3atm1Alb/Ube3atm1Alb
(involves: 129S7/SvEvBrd) 		audiogenic seizures J:50811
Ube3atm1Jwf/Ube3a+
(B6.129S4-Ube3atm1Jwf) 		abnormal spike wave discharge J:102546, J:75622, J:95305
Ube3atm1Yelg/Ube3a+
(involves: 129P2/OlaHsd * 129S2/SvPasCrl) 		audiogenic seizures J:222400
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu
(FVB.Cg-Ugt1tm1.1Afmu) 		seizures J:216224
Unc13btm2Bros/Unc13btm2Bros
(Not Specified) 		sporadic seizures J:77339
Usf1tm1Msw/Usf1tm1Msw
(involves: 129S7/SvEvBrd * C57BL/6) 		environmentally induced seizures J:46788
sporadic seizures J:46788
Usf2tm1Msw/Usf2tm1Msw
(involves: 129S7/SvEvBrd * C57BL/6) 		sporadic seizures J:46788
Usp18tm1Dez/Usp18tm1Dez
(involves: 129S1/Sv * 129X1/SvJ) 		convulsive seizures J:78821
Vcptm1Itl/Vcp+
(B6.129S-Vcptm1Itl) 		seizures J:166230
tonic-clonic seizures J:166230
Wwoxem1Mald/Wwoxem1Mald
(FVB/N-Wwoxem1Mald) 		convulsive seizures J:339564
tonic-clonic seizures J:339564
Xrcc1tm1Pmc/Xrcc1tm1Pmc
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * C57BL/6 * SJL) 		seizures J:152528
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: C57BL/6 * DBA/2) 		increased susceptibility to pharmacologically induced seizures J:121330
Zfp14tm1b(KOMP)Wtsi/Zfp14tm1b(KOMP)Wtsi
(C57BL/6N-Zfp14tm1b(KOMP)Wtsi/J) 		convulsive seizures J:211773
Zfp24hmcns-2J/Zfp24hmcns-2J
(CByJ(Cg)-Zfp24hmcns-2J/GrsrJ) 		tonic seizures J:202595
Zfp24hmcns/Zfp24hmcns
(C3.Cg-a Zfp24hmcns/GrsrJ) 		tonic seizures J:156938
Zfp24tm1.1Pop/Zfp24tm1.1Pop
Cnptm1(cre)Kan/Cnp+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		tonic seizures J:156938
Zfp24tm1.2Pop/Zfp24tm1.2Pop
(involves: 129S4/SvJae * C57BL/6) 		tonic seizures J:156938
Zfp597tm1Hnawa/Zfp597+
(B6.Cg-Zfp597tm1Hnawa) 		seizures J:278329
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/16/2024
MGI 6.23 		The Jackson Laboratory